Mario Rizzetto
#76,825
Most Influential Person Now
Italian physician
Mario Rizzetto's AcademicInfluence.com Rankings
Mario Rizzettophilosophy Degrees
Philosophy
#3818
World Rank
#6106
Historical Rank
Logic
#1504
World Rank
#2271
Historical Rank
Download Badge
Philosophy
Mario Rizzetto's Degrees
- Doctorate Medicine University of Turin
Why Is Mario Rizzetto Influential?
(Suggest an Edit or Addition)According to Wikipedia, Mario Rizzetto is an Italian virologist who in 1977 first reported the Hepatitis D virus as a nuclear antigen in patients infected with HBV who had severe liver disease. He graduated in Medicine and Surgery at the University of Padua in 1969. He was awarded the King Faisal International Prize in Medicine in 1985, the Robert Koch Prize in 1987, the William Beaumont Prize of the American Gastroenterological Association in 1988, and the Hans Popper Award in 1992.
Mario Rizzetto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. (2004) (2954)
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (2003) (2619)
- Telaprevir for previously untreated chronic hepatitis C virus infection. (2011) (2539)
- Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. (2002) (1129)
- Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. (2003) (1015)
- Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. (2006) (879)
- Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. (1977) (836)
- Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association (2002) (751)
- Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis (2003) (706)
- A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease (2005) (668)
- Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005) (652)
- Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. (1980) (466)
- Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. (2005) (462)
- Oxford Textbook of Clinical Hepatology (1999) (455)
- Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. (2016) (425)
- INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B (1982) (405)
- Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. (2005) (403)
- delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. (1980) (381)
- Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. (1983) (357)
- Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. (1986) (347)
- SEROLOGICAL RESPONSE TO THE HEPATITIS DELTA VIRUS IN HEPATITIS D (1987) (304)
- Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. (2007) (285)
- Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine (2004) (284)
- Peginterferon-2a and Ribavirin Combination Therapy in Chronic Hepatitis C (2004) (280)
- Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial (2008) (272)
- Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope (1986) (268)
- Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver (2004) (260)
- Chronic hepatitis D: A vanishing disease? An Italian multicenter study (2000) (249)
- The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference * (2011) (245)
- A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients. (2005) (245)
- Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. (2011) (236)
- A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. (1990) (229)
- Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. (2004) (229)
- EPIDEMIOLOGY OF HBV-ASSOCIATED DELTA AGENT: GEOGRAPHICAL DISTRIBUTION OF ANTI-DELTA AND PREVALENCE IN POLYTRANSFUSED HBsAg CARRIERS (1980) (225)
- Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. (2001) (225)
- Microsomal antibodies in active chronic hepatitis and other disorders. (1973) (218)
- Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. (2005) (217)
- Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta (2006) (217)
- Hepatitis D: thirty years after. (2009) (211)
- Hypoadiponectinemia Predicts the Severity of Hepatic Fibrosis and Pancreatic Beta-Cell Dysfunction in Nondiabetic Nonobese Patients with Nonalcoholic Steatohepatitis (2005) (188)
- The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. (1980) (183)
- Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence (2005) (178)
- INCIDENCE AND SIGNIFICANCE OF ANTIBODIES TO DELTA ANTIGEN IN HEPATITIS B VIRUS INFECTION (1979) (170)
- Infection with the delta agent in chronic HBsAg carriers. (1981) (169)
- Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C (2009) (168)
- Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis (2006) (165)
- Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. (2003) (165)
- Long‐term follow‐up of patients with chronic hepatitis C treated with different doses of interferon‐α2b (1993) (163)
- Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. (2006) (156)
- Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). (2006) (149)
- Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2 (2002) (148)
- MULTICENTRE STUDY OF PREVALENCE OF HBV-ASSOCIATED DELTA INFECTION AND LIVER DISEASE IN DRUG-ADDICTS (1982) (142)
- Effect of macrovescicular steatosis and other donor and recipient characteristics on the outcome of liver transplantation (2001) (142)
- Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. (1983) (137)
- Radioimmunoassay detection of igm antibodies to the hbv‐associated delta (δ) antigen: Clinical significance in δ infection (1982) (134)
- Characterization of antimitochondrial antibodies in healthy adults (1998) (134)
- Hepatitis D Virus: Introduction and Epidemiology. (2015) (131)
- Treatment of hepatitis D (2005) (130)
- Helicobacter species and liver diseases: association or causation? (2008) (128)
- Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin. (2002) (122)
- Delta hepatitis agent: structural and antigenic properties of the delta-associated particle (1984) (120)
- Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation (2004) (118)
- Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. (1983) (118)
- Italian blood donors with anti-HBc and occult hepatitis B virus infection (2007) (112)
- Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study (2005) (111)
- Outcome of chronic delta hepatitis in Italy: a long-term cohort study. (2010) (111)
- A randomized controlled trial of a 12‐month course of recombinant human interferon‐α in chronic delta (type D) hepatitis: A multicenter Italian study (1991) (110)
- Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection. (2018) (107)
- Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? (2000) (104)
- Signal Transducers and Activators of Transcription 3 Signaling Pathway: An Essential Mediator of Inflammatory Bowel Disease and Other Forms of Intestinal Inflammation (2005) (104)
- Covered metal stents for management of inoperable malignant colorectal strictures. (2000) (104)
- High sustained virologic response rates in rapid virologic response patients in the large real‐world PROPHESYS cohort confirm results from randomized clinical trials (2012) (104)
- Changing pattern of chronic hepatitis D in Southern Europe. (1999) (104)
- The predominance of hepatitis delta virus genotype I among chronically infected Italian patients (1997) (104)
- Laboratory evaluation of the patient with liver disease. (2004) (103)
- Type D hepatitis: The clinical significance of hepatitis D virus RNA in serum as detected by a hybridization‐based assay (1986) (102)
- Types of `reticulin' antibodies detected in human sera by immunofluorescence (1973) (101)
- Anticardiolipin antibodies in patients with liver disease (1999) (99)
- Delta hepatitis--present status. (1985) (98)
- Reperfusion damage to the bile canaliculi in transplanted human liver (1996) (96)
- Incidence of Type 2 Diabetes Mellitus and Glucose Abnormalities in Patients With Chronic Hepatitis C Infection by Response to Treatment: Results of a Cohort Study (2008) (95)
- A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy (1989) (93)
- Epidemiology of Hepatitis D (2012) (93)
- Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. (1996) (92)
- Efficacy and Efficiency of Oral Microemulsion Cyclosporin Versus Intravenous and Soft Gelatin Capsule Cyclosporin in the Treatment of Severe Steroid‐Refractory Ulcerative Colitis: An Open‐Label Retrospective Trial (1998) (92)
- Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients (2001) (90)
- Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D (1991) (90)
- Chronic Hepatitis in Carriers of Hepatitis B Surface Antigen, with Intrahepatic Expression of the Delta Antigen (1983) (87)
- Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders. (1991) (86)
- Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. (2005) (85)
- Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. (1986) (84)
- Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. (1999) (84)
- Hepatitis delta virus as a global health problem. (1990) (83)
- Hepatic Disorders Associated with Liver/Kidney Microsomal Antibodies (1974) (83)
- Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. (2004) (83)
- Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. (2007) (83)
- Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver‐kidney microsomes (1995) (82)
- Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection. (1995) (82)
- LIVER TRANSPLANTATION IN HEPATITIS DELTA VIRUS DISEASE (1987) (81)
- An Update on Hdv: Virology, Pathogenesis and Treatment (2013) (80)
- Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease (2007) (80)
- Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct‐acting antiviral agents (2018) (80)
- Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. (2000) (80)
- Hepatitis B virus unable to secrete e antigen. (1991) (78)
- Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine‐resistant mutants (2005) (77)
- Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. (1987) (76)
- Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. (2005) (76)
- Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. (1983) (76)
- Ribavirin treatment for chronic hepatitis D: a pilot study. (2008) (75)
- AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. (2007) (75)
- Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen. (1982) (74)
- Infliximab for treatment of steroid-refractory ulcerative colitis. (2002) (73)
- Perinatal transmission of the hepatitis b virus and of the hbv‐associated delta agent from mothers to offspring in northern italy (1982) (72)
- Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial (1999) (72)
- A histological study of hepatitis delta virus liver disease (1986) (71)
- P.102 Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy (2006) (68)
- Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. (2011) (68)
- Digestive Endoscopy Is Not a Major Risk Factor for Transmitting Hepatitis C Virus (2005) (68)
- CLINICAL SIGNIFICANCE OF ANTIBODY TO THE HEPATITIS DELTA VIRUS IN SYMPTOMLESS HBsAg CARRIERS (1985) (67)
- Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy. (2019) (67)
- Endosonography in decision making and management of gastrointestinal endocrine tumors. (1999) (66)
- Intrafamilial transmission of hepatitis delta virus: molecular evidence. (1999) (65)
- Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease. (1988) (64)
- Advances in hepatitis D virus biology and disease. (1994) (64)
- Response of pre‐core mutant chronic hepatitis B infection to lamivudine (2000) (63)
- Long‐term follow‐up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver‐related complications (2007) (63)
- Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study. (1985) (63)
- Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. (2010) (63)
- Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. (2003) (62)
- Chronic HBV-related liver disease. (2008) (62)
- Epidemiology of hepatitis delta virus: overview. (1991) (61)
- Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope (1998) (61)
- Clinical and virological heterogeneity of hepatitis delta in different regions world‐wide: The Hepatitis Delta International Network (HDIN) (2018) (60)
- Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas. (2018) (59)
- Monoethylglicinexylidide test: A prognostic indicator of survival in cirrhosis (1994) (58)
- Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey. (1988) (58)
- The adventure of delta (2016) (58)
- Hepatitis delta virus disease. (1986) (58)
- Treatment of chronic hepatitis B: recommendations from an Italian workshop. (2008) (58)
- Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. (2002) (57)
- HCV genotypes in patients with liver disease of different stages and severity. (1997) (56)
- Capsule enteroscopy vs. other diagnostic procedures in diagnosing obscure gastrointestinal bleeding: a cost–effectiveness study (2007) (55)
- Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. (1974) (55)
- Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease (2016) (54)
- Prevalence of Hepatitis D in the Eastern Mediterranean Region: Systematic Review and Meta Analysis (2013) (54)
- Highly sensitive alpha‐fetoprotein, Lens culinaris agglutinin‐reactive fraction of alpha‐fetoprotein and des‐gamma‐carboxyprothrombin for hepatocellular carcinoma detection (2016) (53)
- 104 BOCEPREVIR (B) COMBINATION THERAPY IN NULL RESPONDERS (NR): RESPONSE DEPENDENT ON INTERFERON RESPONSIVENESS (2008) (53)
- Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. (2003) (53)
- Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy. (2015) (53)
- Fatal multiple systemic embolisms after injection of cyanoacrylate in bleeding gastric varices of a patient who was noncirrhotic but with idiopathic portal hypertension. (2007) (52)
- Safety and efficacy of azathioprine in the maintenance of ciclosporin‐induced remission of ulcerative colitis (2001) (52)
- Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs. (1982) (52)
- Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: Clinical significance (2004) (52)
- Ectopic liver and hepatocarcinogenesis: report of three cases with four years’ follow-up (2004) (50)
- Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C. (2014) (50)
- Textbook of Hepatology (2007) (50)
- Treatment of chronic delta hepatitis with alpha-2 recombinant interferon. (1986) (50)
- A randomized 4‐arm multicenter study of interferon alfa–2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone (2001) (50)
- Hepatitis C virus infection and monoclonal gammopathies not associated with cryoglobulinemia. (1996) (49)
- Interferon treatment for multiple sclerosis (1998) (49)
- Abdominal pain and bowel dysfunction: diagnostic role of intestinal ultrasound (2001) (48)
- Hepatitis delta: the rediscovery. (2013) (47)
- Treatment of idiopathic retroperitoneal fibrosis using cyclosporin (2001) (46)
- Chronic hepatitis D at a standstill: where do we go from here? (2014) (45)
- Inosine Triphosphatase Polymorphisms and Ribavirin Pharmacokinetics as Determinants of Ribavirin-Associate Anemia in Patients Receiving Standard Anti-HCV Treatment (2012) (44)
- Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. (2000) (44)
- Hepatitis delta virus infection in the world: Epidemiological patterns and clinical expression (1992) (44)
- Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine. (2008) (44)
- Acute small-bowel perforation secondary to capsule endoscopy. (2008) (44)
- The changing scenario of hepatitis D. (2021) (43)
- Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication. (2009) (43)
- Preliminary experience with a new cytology brush in EUS-guided FNA. (2009) (43)
- Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014 (2016) (43)
- Long‐term interferon‐α treatment of children with chronic hepatitis delta: a multicentre study (1996) (43)
- Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation. (2010) (42)
- Pegylated interferon therapy of chronic hepatitis D: In need of revision (2015) (42)
- Liver transplantation: the Italian experience. (2002) (41)
- Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial. (1997) (41)
- Sequential versus concomitant administration of ribavirin and interferon alfa‐n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial (1998) (41)
- Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease (2008) (41)
- Association of Helicobacter pylori infection with ischemic stroke of non-cardiac origin: the BAT.MA.N. project study. (2002) (40)
- Treatment of chronic type D (delta) hepatitis with alpha interferon. (1989) (40)
- Safety and Efficacy of Endoscopic Retrograde Cholangiopancreatography in Patients with Post-Liver Transplant Biliary Complications: Results of a Cohort Study with Long-Term Follow-Up (2011) (40)
- Infection with the delta agent in children. (1985) (40)
- Insulated-Tip Knife Endoscopic Mucosal Resection of Large Colorectal Polyps Unsuitable for Standard Polypectomy (2007) (39)
- Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen‐negative chronic hepatitis B (2004) (39)
- 46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES) (2004) (39)
- Impact of viral eradication with sofosbuvir‐based therapy on the outcome of post‐transplant hepatitis C with severe fibrosis (2017) (39)
- Osteoporosis: still a typical complication of primary biliary cirrhosis? (2003) (38)
- Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease. (2009) (38)
- Identification of HBV DNA sequences that are predictive of response to lamivudine therapy (2004) (38)
- Chronic Helicobacter Pylori Infection and Migraine: A Case‐Control Study (2000) (38)
- Helicobacter pylori and Coronary Heart Disease: Which Directions for Future Studies? (2003) (37)
- Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis. (1987) (37)
- HBsAg kinetics in chronic hepatitis D during interferon therapy: on‐treatment prediction of response (2016) (37)
- Diagnosis of deep‐seated lymphomas by endoscopic ultrasound‐guided fine needle aspiration combined with flow cytometry (2012) (37)
- Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon‐treated patients and in patients who underwent liver transplantation (1998) (37)
- Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop. (2011) (36)
- Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees (1988) (36)
- Multicentre retrospective study on endoscopic ultrasound complications. (2006) (35)
- Antiviral Activity of ANA773, an Oral Inducer of Endogenous Interferons that Acts Via TLR7, in Chronic Hepatitis C Patients (2011) (35)
- Digestive and Liver Disease (2011) (35)
- Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. (1974) (35)
- Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients. (2001) (35)
- Hepatitis D: virology, clinical and epidemiological aspects. (2000) (34)
- Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis? (2010) (34)
- Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures (2015) (34)
- Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment (2012) (33)
- Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor (2009) (33)
- HLA‐DR Antigens in HBsAg‐Positive Chronic Active Liver Disease with and without Associated Delta Infection (1984) (32)
- Risk management of HBsAg or anti-HCV positive healthcare workers in hospital. (2001) (32)
- Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis. (1997) (32)
- Helicobacter pylori in celiac disease and in duodenal intraepithelial lymphocytosis: Active protagonist or innocent bystander? (2015) (32)
- Sorafenib in hepatocellular carcinoma: prospective study on adverse events, quality of life, and related feasibility under daily conditions (2013) (32)
- Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II. (2017) (32)
- Unexplained Common Bile Duct Dilatation With Normal Serum Liver Enzymes: Diagnostic Yield of Endoscopic Ultrasound and Follow-up of This Condition (2014) (31)
- Fatal liver failure following food supplements during chronic treatment with montelukast. (2007) (31)
- Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. (2001) (31)
- Dane Particle‐Associated Hepatitis B e Antigen in Patients with Chronic Hepatitis B Virus Infection and Hepatitis B e Antibody (2007) (31)
- Pancreatic cancer imaging: the new role of endoscopic ultrasound. (2007) (31)
- Is hepcidin the bridge linking Helicobacter pylori and anemia of chronic infection? A research proposal. (2004) (31)
- Oral microemulsion cyclosporin to reduce steroids rapidly in chronic active ulcerative colitis. (1999) (31)
- Treatment of Chronic Delta Hepatitis (2011) (30)
- The Practice of Percutaneous Liver Biopsy in a Gastrohepatology Day Hospital: A Retrospective Study on 835 Biopsies (2007) (30)
- Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. (1989) (30)
- A radioimmunoassay for HBcAg in the sera of HBsAg carriers: Serum HBcAg, serum DNA polymerase activity, and liver HBcAg immunofluorescence as markers of chronic liver disease (1981) (30)
- Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C. (2013) (30)
- Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis. (2004) (30)
- Experimental transmission of the delta agent to chimpanzees. (1983) (30)
- Hepatitis delta: the virus and the disease. (1990) (30)
- HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. (2012) (30)
- Hepatitis delta virus (HDV) infections. Epidemiological and clinical heterogeneity. (1991) (29)
- Management of Hepatitis C virus Genotype 2 or 3 Infection: Treatment Optimization on the Basis of Virological Response (2009) (29)
- Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis. (2011) (29)
- The Natural History of Gastrointestinal Subepithelial Tumors Arising From Muscularis Propria: An Endoscopic Ultrasound Survey (2009) (29)
- Mixed cryoglobulinaemia and chronic hepatitis C virus infection: The rheumatic manifestations (2002) (29)
- Severe steroid-unresponsive ulcerative colitis (2000) (29)
- Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single‐nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4 (2011) (29)
- A randomized 4‐arm multicenter study of interferon alfa‐2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy (2002) (29)
- Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm (2013) (29)
- Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study. (1986) (28)
- Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. (1981) (28)
- Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin. (2005) (28)
- Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen-associated delta antigen (1981) (28)
- Serum heat shock protein 27 levels in patients with hepatocellular carcinoma (2013) (28)
- LONG-LASTING ABATEMENT OF HBsAg SYNTHESIS INDUCED BY ACUTE DELTA INFECTION (1983) (28)
- Long-Term Follow-Up of Previous Hepatitis C Virus Positive Nonresponders to Interferon Monotherapy Successfully Retreated with Combination Therapy: Are They Really Cured? (2006) (28)
- Hepatitis delta virus infection of the liver: progress in virology, pathobiology, and diagnosis. (1988) (28)
- Prevalence of Hepatitis Delta Virus (HDV) Infection in Chronic Hepatitis B Patients with Unusual Clinical Pictures (2013) (28)
- Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: Experience from a nosocomial cluster of infection (2013) (28)
- Immunofluorescence detection of new antigen-antibody system (S/anti-5) associated to hepatitis B virus in liver and in serum of HBsAg carriers (2006) (27)
- Liver transplantation in carriers of the HBsAg. (1991) (27)
- Evaluation of Hepatic Function in Liver Cirrhosis (Clinical Utility of Galactose Elimination Capacity, Hepatic Clearance of D-Sorbitol, and Laboratory Investigations) (1999) (27)
- Efficacy of lamivudine in HBeAg‐negative chronic hepatitis B (2002) (27)
- The first one thousand liver transplants in Turin: a single‐center experience in Italy (2005) (27)
- Usefulness of a Liver Biopsy in the Evaluation of Patients with Elevated ALT Values and Serological Markers of Hepatitis Viral Infection (2001) (27)
- Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation (2002) (27)
- Panenteric IBD-Like Disease in a Patient with Regressive Autism Shown for the First Time by the Wireless Capsule Enteroscopy: Another Piece in the Jigsaw of this Gut-Brain Syndrome? (2005) (27)
- Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin (2009) (27)
- Riboprobe assay for HDV RNA: A sensitive method for the detection of the HDV genome in clinical serum samples (1990) (26)
- Current management of delta hepatitis (2013) (26)
- Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. (2013) (26)
- Hepatitis D: the comeback? (2009) (26)
- TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses (2001) (25)
- Epilepsy and celiac disease: review of literature. (2011) (25)
- Safety of propofol in cirrhotic patients undergoing colonoscopy and endoscopic retrograde cholangiography: results of a prospective controlled study (2012) (25)
- Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis. (2004) (25)
- Autistic enterocolitis: confirmation of a new inflammatory bowel disease in an Italian cohort of patients (2005) (24)
- Randomized Controlled Trial of the NS5A Inhibitor Daclatasvir plus Pegylated Interferon and Ribavirin for HCV Genotype-4 (COMMAND-4) (2015) (24)
- The long‐term efficacy of interferon alfa in chronic hepatitis C patients: A critical review (1995) (24)
- Use of arterial conduit as an alternative technique in arterial revascularization during orthotopic liver transplantation. (2002) (24)
- Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study. (1996) (24)
- OPTIMIZE trial: Non-inferiority of twice-daily telaprevir versus administration every 8 hours in treatment-naïve, genotype 1 HCV infected patients (2013) (24)
- Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view. (2005) (24)
- The epidemiology of hepatitis C virus infection. An update for clinicians. (2004) (24)
- Hepatitis delta virus infection of the liver. (1984) (24)
- UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells. (2014) (24)
- Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study. (2003) (24)
- Endoscopic ultrasound-fine needle aspiration (EUS-FNA) for pancreatic lesions: effectiveness in clinical practice. (2007) (24)
- A randomized trial of pegylated‐interferon‐α2a plus ribavirin with or without amantadine in the re‐treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin (2006) (23)
- Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? (2002) (23)
- Hepatitis D: Clinical Features and Therapy (2010) (23)
- Non-alcoholic steatohepatitis in patients cared in metabolic units. (2004) (23)
- IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients. (2014) (23)
- Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment (2004) (23)
- An ultrastructural and immunohistochemical study on the δ antigen associated with the hepatitis B virus (1979) (23)
- Familial high-density lipoprotein deficiency (tangier disease): The third Italian case (1988) (23)
- Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. (1999) (22)
- Successful closure of a postsurgical benign esophagomediastinal fistula by temporary placement of a polyester, expandable stent: Case report and review. (2002) (22)
- Potential role for the common cystic fibrosis &Dgr;F508 mutation in Crohn's disease (2007) (22)
- Treatment of irritable bowel syndrome. A case control experience. (2006) (22)
- The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data. (2004) (22)
- Efficacy of Irbesartan, a Receptor Selective Antagonist of Angiotensin II, in Reducing Portal Hypertension (2002) (22)
- 780 PREDICTORS OF SVR IN NAIVE HCV G1 PATIENTS IN REAL LIFE PRACTICE: THE PROBE (2008) (22)
- Ectopic Livers and Related Pathology: Report of Three Cases of Benign Lesions (2005) (22)
- Self-expanding covered esophageal ultraflex stent for palliation of malignant colorectal anastomotic obstruction complicated by multiple fistulas. (2000) (22)
- Hepatic involvement in larva migrans of Toxocara canis: report of a case with pathological and radiological findings. (2006) (22)
- Hepatitis B core‐related antigen kinetics in chronic hepatitis B virus genotype D‐infected patients treated with nucleos(t)ide analogues or pegylated‐interferon‐α (2017) (21)
- Helicobacter pylori infection in patients with Hepatitis C Virus positive chronic liver diseases. (2003) (21)
- Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension? (2005) (21)
- Ischemic cardiovascular disease and Helicobacter pylori. Where is the link? (2000) (21)
- HDV: thirty years later. (2011) (21)
- Non‐invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data (2015) (21)
- The Effect of the Eradication of Helicobacter pylori Infection on Hemorrhage Because of Duodenal Ulcer (2001) (21)
- Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection. (1982) (20)
- Microsomal autoantibodies in chronic infections with HBsAg associated delta agent (1983) (20)
- a agent: Association of a antigen with hepatitis B surface antigen and RNA in serum of B-infected chimpanzees (20)
- Experimental infection of chimpanzees with the HBsAg‐Associated delta (δdL) agent: An ultrastructural study (1984) (20)
- Elevated serum chromogranin A in patients with hepatocellular carcinoma (2002) (20)
- Women and celiac disease: association with unexplained infertility. (2007) (19)
- Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease. (1976) (19)
- Liver transplantation for erythropoietic protoporphyria: report of a case with medium-term follow-up. (2000) (19)
- Zafirlukast-related hepatitis: report of a further case. (2001) (19)
- Chronic hepatitis C virus infection and lymphoproliferative disorders: Mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B‐cell non‐Hodgkin lymphoma (2015) (19)
- A retrospective study on a cohort of patients with lymphocytic colitis. (2010) (19)
- Add‐on peginterferon alfa‐2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen‐negative chronic hepatitis B genotype D (2018) (19)
- Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa‐2a/ribavirin (2012) (19)
- Liver transplantation in Italy: current status (2000) (19)
- Thymosin alpha‐1 with peginterferon alfa‐2a/ribavirin for chronic hepatitis C not responsive to IFN/ribavirin: an adjuvant role? (2012) (19)
- Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. The Como cross-sectional study. (2001) (19)
- Epidemiology of hepatitis delta virus (HDV) infection (1985) (19)
- Therapy of chronic hepatitis C: a critical review. (2003) (19)
- Helicobacter pylori Seroprevalence in Patients with Autoimmune Hepatitis (2002) (19)
- G-cell counts in antral endoscopic biopsies by immunofluorescence. (1977) (18)
- Treatment of early chronic delta hepatitis with lymphoblastoid alpha interferon: a pilot study. (1992) (18)
- Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells (2018) (18)
- Endemic HBV infection, tissue autoantibodies and HLA. Analysis of a Sardinian population. (2008) (18)
- Treatment of recurrent hepatitis C virus infection after liver transplantation. (1999) (18)
- Experimental HBV and δ infections of chimpanzees: Occurrence and significance of intrahepatic immune complexes of HBcAg and δ antigen (1981) (18)
- Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study. (2012) (18)
- Detection of serum HDV RNA by RT-PCR. (2004) (18)
- Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation (2013) (18)
- 45 HBsAg seroconversion in adefovir dipivoxil (ADV) treated chronic hepatitis B (CHB) patients (2004) (18)
- Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection (1983) (18)
- Targeting Hepatitis D (2018) (18)
- Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis (2012) (18)
- Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays. (2014) (17)
- Superimposed hepatitis and the effect on viral replication in chronic hepatitis B. (1986) (17)
- Detection of hepatitis delta virus RNA by a nonradioactive in situ hybridization procedure. (1992) (17)
- Prevalence of Helicobacter pylori infection and intestinal metaplasia in subjects who had undergone surgery for gastric adenocarcinoma in Northwest Italy. (2005) (17)
- Pattern Analysis of Serum alpha-fetoprotein in the Early Diagnosis of Hepatocellular Carcinoma in Liver Cirrhosis (1988) (17)
- Viral hepatitis in the third millennium. (1998) (17)
- The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta. (2015) (17)
- An update on AIDS-related cholangiopathy. (2009) (17)
- Preoperative endoscopic ultrasonography in decision making and management for pancreatic endocrine tumors: a 6-year experience. (1998) (17)
- Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. (2014) (17)
- The medical impact of hepatitis D virus infection in Uzbekistan (2019) (16)
- Diagnostic significance of IgM antibody to hepatitis delta virus in fulminant hepatitis B (1990) (16)
- Laparoscopic Cholecystectomy in Cirrhotic Patients (2001) (16)
- Endpoints and New Options for Treatment of Chronic Hepatitis D (2021) (16)
- 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation (2021) (16)
- 2008 Clinical approach to irritable bowel syndrome. (2008) (16)
- Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis. (2016) (16)
- How accurate is the culture of Helicobacter pylori in a clinical setting? An appraisal. (2005) (16)
- Appropriateness of colonoscopy in a digestive endoscopy unit: a prospective study using ASGE guidelines. (2009) (16)
- Performance of sequence analysis, INNO‐LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations (2006) (16)
- Loss of Tubuloglomerular Feedback in Decompensated Liver Cirrhosis: Physiopathological Implications (2005) (15)
- Hepatitis Delta-Virus (2019) (15)
- Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study. (2019) (15)
- Helicobacter pylori seropositivity in patients with unstable angina. (2003) (15)
- Treatment of chronic hepatitis D with thymus-derived polypeptide thymic humoral factor-gamma 2: a pilot study. (2002) (15)
- The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis. (2009) (15)
- Pathobiology of hepatitis delta virus. (1993) (15)
- Adrenaline plus cyanoacrylate injection for treatment of bleeding peptic ulcers after failure of conventional endoscopic haemostasis. (2002) (15)
- Treatment of hepatitis D, an unmet medical need. (2020) (15)
- Long-term evolution of chronic delta hepatitis in children. (1993) (15)
- Treatment of hepatitis B e antigen-negative chronic hepatitis B with lamivudine. (2003) (15)
- Midodrine in the prevention of hepatorenal syndrome type 2 recurrence: a case-control study. (2009) (15)
- The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species. (2001) (15)
- Interferon β-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C (2005) (15)
- Prevalence of Non-Organ-Specific Autoantibodies in Patients Suffering from Duodenal Ulcer With and Without Helicobacter pylori Infection (2004) (15)
- Role of endoscopy in the management of gastroenteropancreatic neuroendocrine tumours. (2011) (14)
- [Intestinal metaplasia, dysplasia, gastric cancer and Helicobacter pylori: epidemiological observations]. (2005) (14)
- Effect of patient characteristics on hospital costs for cirrhosis: implications for the disease-related group (DRG) reimbursement system. (1996) (14)
- Seroprevalence of Helicobacter pylori infection among blood donors in Torino, Italy. (2001) (14)
- Acute myocardial infarction andHelicobacter pylori seropositivity (1999) (14)
- Prevalence of delta antibodies among urban HBsAg-positive chronic liver disease patients in Egypt. (1988) (14)
- Liver transplantation in cirrhotic patients with portal vein thrombosis: A single centre experience (2014) (14)
- Liver transplantation for early‐detected, multifocal hepatocellular carcinoma (2001) (14)
- Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study. (2002) (14)
- Pulmonary embolism due to compression of the inferior vena cava by a hepatic hemangioma. (1993) (14)
- EASL Meeting Report Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis q (2006) (14)
- Narrow band imaging vs. high definition colonoscopy for detection of colorectal adenomas in patients with positive faecal occult blood test: a randomised trial. (2014) (14)
- Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment. (2013) (13)
- ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy. (2015) (13)
- Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. (2004) (13)
- Long-term (3-year) Therapy with Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen Negative Chronic Hepatitis B (2005) (13)
- Sequential versus concomitant administration of ribavirin and interferon alfa-N3 in patients with chronic hepatitis C not responding to interferon alone. Results of a randomized controlled trial (1998) (13)
- Solute-free water retention in preascitic cirrhotic rats following intravenous water loading. (2009) (13)
- Occult Hepatitis B Virus Infection in Patients With Chronic Hepatitis C Treated With Antiviral Therapy (2012) (13)
- Patients with acute myocardial infarction in northern Italy are often infected by Helicobacter pylori. (1999) (13)
- Current pharmacotherapy for the treatment of chronic hepatitis B (2003) (13)
- Potential relationship between Helicobacter pylori and ischemic heart disease: any pathogenic model? (2008) (13)
- Thymalfasin in the treatment of hepatitis B and C (2010) (13)
- Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis. (2006) (13)
- Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view. (2006) (13)
- Prolonged, polyphasic infection with hepatitis A. (1986) (13)
- Endoscopic ultrasound in common bile duct dilatation with normal liver enzymes. (2015) (13)
- Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. (2009) (13)
- Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children. (1991) (13)
- Is serum uric acid a predictive factor of response to IFN‐treatment in patients with chronic hepatitis C infection? (2008) (13)
- Therapy of chronic viral hepatitis: a critical view. (1999) (13)
- Renal tubular events following passage from the supine to the standing position in patients with compensated liver cirrhosis: loss of tubuloglomerular feedback (2002) (13)
- Predictors of response to interferon therapy (1996) (13)
- 106 ADRENAL DYSFUNCTION IN NONSEPTIC CIRRHOTIC PATIENTS WITH ASCITES: IMPACT ON SURVIVAL (2011) (12)
- Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner. (2014) (12)
- Previous tuberculosis, hepatitis C virus and lichen planus. A report of 10 cases, a causal or casual link? (2000) (12)
- Identification of a new WASP and FKBP-like (WAFL) protein in inflammatory bowel disease: a potential marker gene for ulcerative colitis (2008) (12)
- Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. (1974) (12)
- Tissue stem cells and cancer stem cells: potential implications for gastric cancer. (2008) (12)
- Monomeric (7S) immunoglobulin M antibodies to hepatitis delta virus in hepatitis type D. (1990) (12)
- Hepatitis delta virus: From structure to disease expression (1992) (12)
- Helicobacter pylori eradication: metronidazole or tinidazole? Data from Turin, Italy. (2008) (12)
- A 2008 panorama on osteoporosis and inflammatory bowel disease. (2008) (12)
- Radioimmunoassay detection of IgM antibodies to the hepatitis B core antigen in HBsAg liver disease. (1982) (11)
- 162 Role of Interferon Response During RE-Treatment of Null Responders with Boceprevir Combination Therapy: Results of Phase II Trial (2008) (11)
- High-grade B-cell lymphoma arising in mucosa-associated lymphoid tissue of the duodenum. (2002) (11)
- Re-treatment with interferon-beta of patients with chronic hepatitis C virus infection (2002) (11)
- Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. (1998) (11)
- Posttransplantation prevention and treatment of recurrent hepatitis B (2000) (11)
- Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. (2007) (11)
- Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study. (2007) (11)
- Local Tumor Progression of Hepatocellular Carcinoma After Microwave Percutaneous Ablation: A Preliminary Report (2012) (10)
- Lymphocytic gastritis and protein-losing gastropathy. (2000) (10)
- Clinical significance of HDV RNA in HDV disease. (1987) (10)
- OC-30 Adrenal dysfunction in nonseptic cirrhotic patients with ascites: Impact on survival (2011) (10)
- Declining prevalence and increasing awareness of hepatitis C virus infection in Italy: a population-based survey (2017) (10)
- Myrcludex B, a novel therapy for chronic hepatitis D? (2016) (10)
- Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report. (2005) (10)
- Response-Guided Therapy: Optimizing Treatment now and in the Future (2008) (10)
- Mixed cryoglobulinaemia associated with hepatitis C virus infection: A predictor factor for treatment with interferon? (1999) (10)
- 829 EFFECTIVENESS OF HEPATITIS C VIRUS TREATMENT IN REAL-LIFE PRACTICE: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY IN ITALY (PROBE) (2008) (10)
- The dilemma for patients with chronic hepatitis C: treat now or warehouse? (2014) (10)
- Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment. (1998) (10)
- Transcatheter arterial chemoembolization for hepatocellular carcinoma in cirrhosis: influence on portal hypertension (2011) (10)
- Antiplatelet and anticoagulant drugs management before gastrointestinal endoscopy: do clinicians adhere to current guidelines? (2015) (9)
- 74 THE ANTIVIRAL RESPONSE TO TENOFOVIR DISOPROXIL FUMARATE (TDF) IS COMPARABLE IN LAMIVUDINE (LAM)-NAIVE AND LAM-EXPERIENCED SUBJECTS TREATED FOR CHRONIC HEPATITIS B (CHB) (2008) (9)
- EUS in gastric sarcoidosis. (1999) (9)
- 2002 SLC28A2 65C>T PREDICT SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH HEPATITIS C TREATED WITH INTERFERON AND RIBAVIRIN, CONSIDERING ALL HCV GENOTYPE AND GENOTYPE 1/4 (2010) (9)
- Chronic Hepatitis D; at a Standstill? (2016) (9)
- [Ischemic cardiovascular diseases. Correlation with Helicobacter pylori infection]. (2000) (9)
- Prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease: pilot study. (2010) (9)
- Clinical and Virological Response to Entecavir in HBV-Related Chronic Hepatitis or Cirrhosis: Data from the Clinical Practice in a Single-Centre Cohort (2012) (9)
- Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study. (2015) (9)
- Studies of Therapy with Thymosin α1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C (2007) (9)
- Treatment of chronic hepatitis B: Update of the recommendations from the 2007 (2011) (9)
- CIRRHOSIS AND LIVER CANCER (1985) (9)
- Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant. (2017) (8)
- [Intrahepatic cholestasis in hyperthyroidism]. (1991) (8)
- Hepatitis B virus subtypes and lamivudine resistance (2001) (8)
- IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance. (1987) (8)
- Is smoking a prognostic factor in patients with chronic hepatitis C? (2009) (8)
- Active HBV replication in HBsAg carriers with chronic Delta infection (1985) (8)
- 923 SAFETY AND EFFICACY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE THERAPY IN LAMIVUDINE EXPERIENCED PATIENTS (2009) (8)
- A Practical Guide to the Use of Interferons in the Management of Hepatitis Virus Infections (2012) (8)
- Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non‐neoplastic liver tissues (1997) (8)
- Benign recurrent intrahepatic cholestasis. A clinico-pathologic study (1990) (8)
- Delta hepatitis virus infection in ethiopia (1988) (8)
- Interferon in chronic hepatitis B. (1994) (8)
- Review article: HCV ? STAT-C era of therapy (2010) (8)
- Add-On Peginterferon Alfa-2a Significantly Reduces HBsAg Levels in HBeAg-Negative, Genotype D Chronic Hepatitis B Patients Fully Suppressed on Nucleot(s)ide Analogues Treatment: Final Results of the Hermes Study (2016) (8)
- Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B patients completely responders during 5 years of therapy. (2004) (8)
- Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy. (1987) (8)
- Early and Late Outcome of Patients with Obstructing Colorectal Cancer Treated by Stenting and Elective Surgery: A Comparison with Emergency Surgery and Patients Operated Without Obstructive Symptoms (2004) (8)
- Hepatitis: PEG-IFN for the treatment of hepatitis D (2011) (8)
- Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C. (2005) (8)
- Orthotopic liver transplantation for chronic viral hepatitis: an overview (1992) (8)
- Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection. (2020) (8)
- Hepatitis C virus and human immunodeficiency virus: a dangerous dealing. (2007) (8)
- Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients. (1998) (8)
- [Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report]. (2007) (8)
- Sustained viral load and ALT reduction following 48 weeks of entecavir treatment in HBEAG-negative and -positive patients with chronic hepatitis B who have failed prior lamivudine therapy (2003) (8)
- Evidence of a dynamic aldosterone‐independent distal tubular control of renal sodium excretion in compensated liver cirrhosis * (2005) (8)
- 798 EFFICACY OF TELAPREVIR DOSED TWICE DAILY VERSUS EVERY 8 HOURS BY IL28B GENOTYPE: RESULTS FROM THE PHASE III OPTIMIZE STUDY (2013) (7)
- Hepatitis delta virus (HDV) infection and disease. (1986) (7)
- HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms. (2019) (7)
- Transmission of hepatitis B infection from hepatitis B core antibody—positive livers: Background and prevention (2001) (7)
- Endoscopic banding for esophageal variceal bleeding: technique and patient outcome. (2011) (7)
- Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C. (2007) (7)
- Treatment with interferon alfa-2b of chronic HDV hepatitis in children (1990) (7)
- The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease (2021) (7)
- Extrahepatic aneurysm of the portal venous system and portal hypertension. (2013) (7)
- Patterns of HDV reinfection in liver transplantation (1989) (7)
- Role of screening in prevention and treatment. (1993) (7)
- An ultrastructural and immunohistochemical study on the delta antigen associated with the hepatitis B virus. (1979) (7)
- Detection of hepatitis D virus RNA in serum by a reverse transcription, polymerase chain reaction-based assay (1995) (7)
- The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal (2020) (7)
- 819Daclatasvir in Combination with Peginterferon Alfa-2a and Ribavirin for Treatment-Naive Patients with HCV Genotype 4 Infection: Phase 3 COMMAND-4 Results (2014) (7)
- Hepatitis B vaccination: current status. (1999) (7)
- The role of gastroesophageal reflux disease in chest pain. (2002) (7)
- Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal (2002) (7)
- A trichrome stain for the intrahepatic localization of the hepatitis B surface antigen (HBsAg) (1977) (7)
- Benefit of dietary integrators for treating functional dyspepsia: a prospective pilot study. (2009) (7)
- Treatment with interferon (1991) (7)
- Immunohistochemical research on HDV infection in Chinese patients with chronic liver disease (1990) (7)
- Durability of the response to peginterferon-&agr;2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting (2014) (7)
- Discussion (session IV) (1990) (7)
- Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia (2016) (7)
- F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy (2012) (7)
- A double Meckel's diverticulum as obscure gastrointestinal bleeding cause. Report of a case. (2006) (7)
- Is liver stiffness measurement different in patients with NASH or with viral hepatitis (2008) (7)
- The clinical and immunological significance of a new antigen/antibody system (delta/anti-delta) in chronic carriers of the HBsAg (1978) (7)
- Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant. (2017) (7)
- Lamivudine in anti-HBeAg positive chronic hepatitis B: Response after one year of treatment (2000) (7)
- Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin. (2011) (6)
- Delta virus hepatitis. (1989) (6)
- Hepatitis D (Delta) (2012) (6)
- Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine. (2011) (6)
- Transjugular liver biopsy: a relatively simple procedure with an indefinite past and an expected brilliant future. (2008) (6)
- Enzyme-linked immunosorbent assay for detection of antibody to the HBsAg-associated delta antigen (1981) (6)
- Prospective randomized trial: endoscopic follow up 3 vs 6 months after esophageal variceal eradication by band ligation in cirrhosis. (2014) (6)
- Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen. (1981) (6)
- Human antibodies to mast cells. (1973) (6)
- Prophylaxis of hepatitis B virus infection before liver transplantation, 1990-2001: a single-center experience. (2003) (6)
- Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response. (1987) (6)
- Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE‐I Part II) (2019) (6)
- TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION WITH INTERFERON ALFA 2B AND RIBAVIRIN.: Abstract# 594 (2000) (6)
- Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease. (2006) (6)
- Effect of Helicobacter pylori eradication on bulbitis and duodenal gastric metaplasia. (2004) (6)
- Helicobacter pylori and type 2 diabetes mellitus. Negative results and goals of future studies. (2008) (6)
- PROGNOSTIC SIGNIFICANCE OF IN-VITRO COMPLEMENT FIXATION IN LIVER BIOPSY SPECIMENS FROM PATIENTS WITH ACUTE VIRAL HEPATITIS TYPE B (1976) (6)
- Analysis of cyst fluid obtained by endoscopic ultrasound-guided fine-needle aspiration supporting the diagnosis of a pancreatic neuroendocrine neoplasm. (2011) (6)
- Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women. (2014) (6)
- Intrahepatic localization of the surface (HBsAg) and core (HBcAg) antigenic determinants associated with hepatitis B virus in biopsy samples from patients with liver disease (1976) (6)
- Hepatitis delta virus disease: an overview. (1993) (6)
- Liver transplantation in Italy: current status. Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.). (2000) (6)
- Long-term interferon treatment of chronic hepatitis D: a multicentre Italian study. (1990) (6)
- Investigational drugs in development for Hepatitis D (2017) (6)
- Long-term follow-up of entecavir treated protocol-defined non responders in rollover study ETV-901 (2007) (6)
- Endoscopic ultrasonography in hepatology: focus on portal hypertension. (2008) (6)
- Progress in the prevention and control of viral hepatitis type B: Closing remarks (2002) (6)
- Gastroduodenal fistula complicating a prepyloric ulcer. (1983) (5)
- Treatment of Hepatitis B Virus Cirrhosis (2012) (5)
- Helicobacter Pylori and Insulin Resistance: Time to Do Interventional Studies (2009) (5)
- Sexual transmission of hepatitis C virus: the Turin study. (2001) (5)
- 428 Lamivudine-refractory hepatitis B patients can be safely switched directly to entecavir 1 mg daily therapy (2004) (5)
- PEG-IFN alfa-2a (40kd) (Pegasys) plus amantadine (AMA) or ribavirin (RBV) in naïve patients with chronic hepatitis C (CHC) (2003) (5)
- OC-13 ADVANCE study: Final results of the phase III trial with telaprevir in combination with PEG-IFN and RBV in treatment-naïve genotype 1 HCV (2011) (5)
- Adrenal function and microbial DNA in noninfected cirrhotic patients with ascites: Relationship and effect on survival. (2015) (5)
- Long-term response to interferon-alfa 2b re-treatment in chronic hepatitis C. (1994) (5)
- 13 P Comparing different screening strategies for colorectal cancer (2002) (5)
- Endoscopic ultrasound in the 2013 preoperative evaluation of gastric cancer. (2013) (5)
- Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids: a case report (2004) (5)
- Assessment of liver fibrosis in the clinical setting: something is changing? (2007) (5)
- Hypercalcaemia secondary to hepatocellular carcinoma. (1999) (5)
- Therapy for chronic hepatitis C. Present status. (2000) (5)
- 480 Treatment with adefovir alone or in combination with lamivudine in chronic hepatitis B lamivudine-resistant patients: Results after two years (2006) (5)
- Guidelines for the treatment of chronic viral hepatitis (1997) (5)
- [Need for hospital admission in patients with ulcerative colitis during maintenance with azathioprine]. (2004) (5)
- Efficacy of lamivudine therapy in chronic delta hepatitis: A multicenter randomized controlled pilot study (2003) (5)
- Transfusion-related delta hepatitis. (1988) (5)
- Hepatitis B virus replication and clinical outcome in carriers of HBsAg. Perspectives of treatment with DNA inhibitors. (2008) (5)
- Endoscopic ultrasound-guided fine needle aspiration diagnosis of extramedullary hematopoiesis in mediastinum. (2009) (5)
- The immunological diagnosis of HBsAg liver disease by combined screening for thee system in the serum and the HB core and surface antigens in liver biopsy samples (1977) (5)
- Decreasing eradicaton rate of Helicobacter pylori infection with metronidazole-based triple therapy. A randomised study. (2002) (5)
- Thee antigen and antibody in the serum of patients with HBsAg-positive liver disease and in asymptomatic carriers (1976) (5)
- 241 Long-term (96 weeks) adefovir dipivoxil in HBEAG negative chronic hepatitis results in significant virological, biochemical and histological improvement (2003) (5)
- Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies (2012) (5)
- Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial. (1988) (5)
- Presence and significance of hepatitis B virus replication in chronic type D hepatitis. (1991) (5)
- Liver transplantation in viral hepatitis. New insights. (1999) (5)
- The Italian experience on paediatric liver transplantation: 1988-1999 report. (2002) (4)
- Helicobacter pylori and dementia. Which consistency for an association? (2007) (4)
- Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. (1997) (4)
- 3484 Enteral wallstent for the emergency treatment of acute colonic obstruction due to malignant strictures. (2000) (4)
- Extragastric manifestations of Helicobacter species infection. Do these bacteria act as triggers? (2002) (4)
- The Discovery of the Hepatitis D Virus: Three Princes of Serendip and the Recognition of Autoantibodies to Liver‐Kidney Microsomes (2020) (4)
- Tenofovir DF (TDF) showed superior antiviral efficacy to adefovir dipivoxil in a randomized, double-blind, study for the treatment of HBeAg-negative chronic hepatitis B (CHB) (2008) (4)
- Plasma adiponectin in non alcoholic fatty liver disease is related to hepatic insulin resistance and hepatic fat content (2005) (4)
- 203 Noradrenaline vs terlipressin in hepatorenal syndrome: A prospective, randomized study (2006) (4)
- P.229 HCV-1 subtypes and response to pegylated interferon plus ribavirin therapy (2006) (4)
- Pathobiology of hepatitis delta virus infection at the cell level. (1993) (4)
- Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers (2016) (4)
- [Chronic HCV hepatopathy and cryoglobulinemia. The associated clinical spectrum]. (1999) (4)
- 506 Pegylated interferon alpha-2b monotherapy and in combination with ribavirin in chronic hepatitis delta (2006) (4)
- An aggressive medical approach for inflammatory bowel disease: clinical challenges and therapeutic profiles in a retrospective hospital-based series. (2012) (4)
- How important is mesalamine in the maintenance of steroid-refractory colitis? (2008) (4)
- Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries (2014) (4)
- Epidemiology and Natural History (2007) (4)
- Incidence and significance of different types of connective tissue antibodies in adult and pediatric gastroenterological disorders. (1978) (4)
- ENDOSCOPIC VARICEAL LIGATION FOR PROPHYLAXIS OF ESOPHAGEAL VARICEAL BLEEDING: TECHNICAL ASPECTS AND OUTCOME (2009) (4)
- A randomised 4-arm multicentre study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone (2001) (4)
- Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D? (2018) (4)
- Long term interferon treatment of chronic delta hepatitis: a multicenter Italian study. (1991) (4)
- Inactive hepatitis B virus carriers: a favourable clinical condition. (2005) (4)
- 146 CHRONIC HEPATIC ENCEPHALOPATY (HE) IN PATIENTS WITH SEVERE LIVER CIRRHOSIS: EFFICACY OF THE WHEAT AND MILK PROTEIN FREE DIET IN THE REDUCTION OF CLINICAL EPISODES (2011) (4)
- Azathioprine (AZA) to maintain the response of acute ulcerative colitis (UC) to cyclosporin (1998) (4)
- Portal hypertensive colopathy and hemorrhoids in cirrhotic patients. (2000) (4)
- Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test (1978) (3)
- CLINICAL-LIVER, PANCREAS, AND BILIARY TRACT Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years (2006) (3)
- Quantitation of anti-HBe antibodies in anti-HBc-positive liver donors. (2019) (3)
- Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without hepatitis delta virus infection. Effects of interferon treatment. (1992) (3)
- [The diagnosis of helicobacter pylori infection: guidelines from the Maastricht 2-2000 Consensus Report]. (2004) (3)
- ENDOSCOPIC ULTRASOUND FINE‐NEEDLE ASPIRATION IN THE DIAGNOSIS OF INTRAPANCREATIC ACCESSORY SPLEEN (2011) (3)
- Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients (2022) (3)
- Inflammatory bowel disease: an overview. (2007) (3)
- Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency. (2007) (3)
- Hepatitis D virus(HDV)/hepatitis B virus(HBV) interactions: A molecular and virologic study (1989) (3)
- Instruments and accessories for diagnostic endoscopic ultrasound (radial scanning and miniprobes). (2007) (3)
- In routine clinical practice, few physicians use early viral kinetics to guide HCV dual therapy treatment decisions (2014) (3)
- P.324 Pegylated interferon alpha-2b monotherapy and in combination with ribavirin in chronic hepatitis delta (2006) (3)
- Relative adrenal insufficiency in cirrhosis: Relevance in patients with ascites and treatment with hydrocortisone in refractory ascites (2009) (3)
- [Delta hepatitis virus: 3rd identified hepatitis virus]. (1986) (3)
- A HBV variant is responsible for anti-HBe positive hepatitis B (1989) (3)
- Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal. (2002) (3)
- Forty-Five Years after the Discovery of the Hepatitis D Virus: Where Do We Stand? (2021) (3)
- Treatment of patients with delta hepatitis using interferon. (1986) (3)
- [Gastroesophageal reflux disease and chest pain]. (2001) (3)
- 1186 PEG-IFN alfa-2A (40KD) (PEGASYS) plus amantadine (AMA) or ribavirin (RBV) in naive patients with chronic hepatitis C (CHC) (2003) (3)
- Helicobacter pylori and Coronary Artery Disease: Which Is the Better Target Population? (2007) (3)
- High rate of microscopic colitis in patients with Marsh I–II duodenal damage (2009) (3)
- Risk factors for HCV infection. Focus on ethnic and cultural characteristics. (2009) (3)
- Surgery for carcinoma of the gallbladder. Our experience. (2002) (3)
- AISF position paper on HCV in immunocompromised patients (2019) (3)
- Management of hepatitis D virus infection (1991) (3)
- Delta Hepatitis: Forgotten, but Not Gone (2010) (3)
- Recurrence of hepatitis B in liver transplants treated with antiviral therapy. (1998) (3)
- [Pseudomembranous colitis caused by antibiotics]. (1976) (3)
- Beneficial behavioural effects of IBD therapy and gluten/casein-free diet in an Italian cohort of patients with autistic enterocolitis followed over one year (2006) (3)
- [Gastric cancer and Helicobacter pylori: an interdisciplinary point of view]. (2006) (3)
- Normal lymphocyte interferon production in adult HBsAg‐positive chronic active liver disease (1979) (3)
- Hepatocellular carcinoma in a non-cirrhotic liver. Two case reports and literature review. (2000) (3)
- 905 ADHERENCE WITH TELAPREVIR BID vs. q8h DOSING IN TREATMENT-NAÏVE HCV-INFECTED PATIENTS: RESULTS FROM THE PHASE III OPTIMIZE STUDY (2013) (3)
- Detection of c-myc nuclear oncoprotien in nuclei expressing the hepatitis delta virus antigen (HD-Ag) (1991) (3)
- Hepatitis Delta Virus in Acute and Chronic Liver Disease (1989) (3)
- Safety of anti-HCV-reactive immunoglobulin in heart transplant patients (1992) (3)
- Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group. (2001) (3)
- A trichrome stain for the detection of hepatitis B surface antigen in liver biopsies. (1976) (3)
- A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies. (2005) (3)
- Treatment of chronic hepatitis B. (2002) (3)
- THERAPY OF CHRONIC VIRAL HEPATITIS (1999) (3)
- Epithelial microchimerism: Consistent finding in human liver transplants (2006) (3)
- Association between Crohn's disease and Conn's syndrome. A report of two cases. (2005) (3)
- [Helicobacter pylori and headache: a minireview]. (2007) (3)
- Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucleot(s)ide analogues treatment: HERMES Study Interim Analysis (2015) (3)
- High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin among Patients with Decompensated Cirrhosis who Underwent Liver Transplant during Participation in the Solar-1 and -2 Studies (2016) (3)
- Sustained histologic response is common in the absence of virologic response to interferon (IFN) therapy for chronic hepatitis C (HCV) (1998) (3)
- [The exacerbation of psoriasis during treatment with alfa interferon]. (1997) (3)
- Ghrelin in non-alcoholic fatty liver disease (2003) (2)
- Antibody to hepatitis C virus in the serum of patients with chponic hepatitis (1989) (2)
- The course of anti-HBE/HBV-DNA positive chronic liver disease during long term lamivudine treatment (2003) (2)
- Hepatitis B Virus Reactivation upon Immunosuppression: Is There a Role for Hepatitis B Core-Related Antigen in Patients with Immune-Escape Mutants? A Case Report (2021) (2)
- Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment. (2011) (2)
- A counterimmunoelectrophoretic technique for the detection of HBeAg/anti-HBeAg (e antigen/antibody) in human sera. (1977) (2)
- 20 THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE AND POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102 AND STUDY 103) (2010) (2)
- 15 Open, multicenter, randomized, controlled trial to compare safety and efficacy of r-hIFN beta 1a alone or in combination with ribavirin in HCV naiv patients (2003) (2)
- VIRAL HEPATITIS D AMONG HEMODIALYSIS PATIENTS: A WORLDWIDE UNDERESTIMATED PROBLEM (2009) (2)
- [Invasive diagnosis of Helicobacter pylori infection in the 2006 clinical practice]. (2006) (2)
- Efficacy and safety of Boceprevir-based therapy in HCVG1 treatment-experienced patients with advanced fibrosis/cirrhosis: Italian NPP survey (2014) (2)
- Practical out-patient management of autoimmune hepatitis. (2006) (2)
- Diagnosis of Helicobacter pylori infection: validation of a commercial non invasive salivary test against urea breath test and serology. (2001) (2)
- Epithelioid haemangioendothelioma of the liver: report of a case submitted to orthotopic liver transplantation. (1996) (2)
- PEG-IFN alfa-2a (40KD) plus amantadine (AMA) or ribavirin (RBV) in naive patients with chronic hepatitis C (CHC) (2003) (2)
- ENDOSCOPIC MANAGEMENT OF POST-LIVER-TRANSPLANT BILIARY COMPLICATIONS (2009) (2)
- 995 A COMPARATIVE STUDY BETWEEN ULTRASOUND EVALUATION, LIVER STIFFNESS MEASUREMENT AND BIOPSY FOR STAGING OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE (2009) (2)
- 442 Entecavir 10 mg is consistently superior to lamivudine at 48 weeks across multiple baseline HBV disease characteristics in lamivudine-refractory patients (2004) (2)
- The epidemiology of gastro-oesophageal reflux disease. A brief review. (2003) (2)
- O.064 Antiviral treatment for hepatitis C virus infection in the real practice: A nationwide Italian experience (the PROBE study) (2006) (2)
- Italian trials of interferon alpha in chronic delta hepatitis. (1993) (2)
- Therapy for chronic hepatitis B. Present status. (2000) (2)
- Chronic Delta Hepatitis (1983) (2)
- Letter: HBsAg kinetics‐guided interferon therapy for chronic hepatitis D – authors’ reply (2017) (2)
- Outcome of chronic hepatitis delta in Italy: A long-term cohort study (2009) (2)
- Does HBeAg minus HBV modify the course of HDV superinfection? (1991) (2)
- P.246 The efficacy of a 12 weeks course of pegylated interferon alpha-2b (Peg-IFN) and ribavirin (RBV) is similar to a standard 24 weeks course, regardless of basal viremic level (2006) (2)
- 124Treatment of recurrent hepatitis C after liver transplantation with interferon alfa 2B and ribavirin (2000) (2)
- Recurrent liver disease after liver transplantation. (1997) (2)
- 7 Clinical events during long term lamivudine treatment in anti-HBe/HBV-DNA positive chronic liver diseases (2003) (2)
- [712] IS LIVER STIFFNESS MEASUREMENT DIFFERENT IN PATIENTS WITH NASH OR WITH VIRAL HEPATITIS? (2007) (2)
- PEG-IFN for hepatitis C in clinical practice (2009) (2)
- Endoscopic Ultrasound-Guided Fine Needle Aspiration in the Diagnosis of Pelvic Metastasis of Hepatocellular Carcinoma: Case Report and Review of Literature (2013) (2)
- 1156 48 weeks of adefovir dipivoxil (ADV) results in a consistent and significant improvement in liver histology and virological status regardless of baseline knodell fibrosis score in patients with HBEAG- chronic hepatitis B (2003) (2)
- Evolving challenges of Helicobacter pylori. (2011) (2)
- EUS-GUIDED CYTOLOGIC DIAGNOSIS OF PANCREATIC ENDOCRINE TUMORS (PETS): IMPACT OF ON-SITE CYTOPATHOLOGICAL ASSESSMENT (2009) (2)
- Amantadine in HCV chronic infection: A 6 months follow-up study (1998) (2)
- [Lithiasis of the gallbladder and biliary ducts: from epidemiology to therapy]. (2001) (2)
- [566] PRE-TREATMENT FACTORS PREDICTING SUSTAINED VIROLOGICAL RESPONSE IN TREATMENT-NAIVE HCV GENOTYPE 1 PATIENTS PARTICIPATING IN A LARGE, PRACTICE-BASED NATIONWIDE OBSERVATIONAL STUDY (2007) (2)
- World gastroenterology organisation practice guideline - hepatitis B September 2008 (2009) (2)
- Diversity of clinical presentation and virological characteristics of hepatitis delta in different regions world-wide: results of the Hepatitis Delta International network (2017) (2)
- HDV infection from blood and blood products. (1987) (2)
- THE CHALLENGING DIFFERENTIAL DIAGNOSIS OF SOLID PANCREATIC MASSES: IS THERE A ROLE FOR CONTRAST-ENHANCED EUS (CE-EUS)? (2009) (2)
- [Infections and cardiovascular diseases on an ischemic basis. The case of Helicobacter pylori]. (2000) (2)
- Monitoring antiviral non A non B chronic hepatitis therapy by HCV serum markers (1991) (2)
- P.14.6 ENDOSCOPIC ULTRASOUND-GUIDED SAMPLING OF MEDIASTINAL, PANCREATIC AND GASTROINTESTINAL LESIONS: FINE NEEDLE ASPIRATION (EUS-FNA) AND SAMPLING WITHOUT ASPIRATION (SO-CALLED “CAROTAGE”) (2012) (2)
- Anti-GOR in hepatitis D: specific association with hepatitis C virus superinfection (1994) (2)
- [123] SUSTAINED VIROLOGICAL RESPONSE RATES WITH PEGINTERFERON a-2a (40 kD) (PEGASYS®) PLUS RIBAVIRIN (COPEGUS®) IN RANDOMISED CONTROLLED CLINICAL TRIALS ARE REPLICATED IN THE CLINICAL PRACTICE SETTING (2007) (2)
- A meta analysis of endoscopic ultrasound guided fine needle aspiration (EUS-FNA) accuracy in the diagnosis of solid pancreatic masses (2006) (2)
- Stem cells and Helicobacter-induced gastric cancer: where do we stand at the end of 2006. (2006) (2)
- [Eosinophilic gastroenteritis and ascites. Clinical case]. (1991) (2)
- Hepatitis delta virus infection and disease; the lesson from the liver transplantation model. (1991) (2)
- [Non-invasive diagnosis of Helicobacter pylori infection in the 2006 clinical practice]. (2006) (2)
- Clinical types of HBsAg-positive hepatitis. (1993) (2)
- Long term lamivudine monotherapy in chronic E-antigen negative hepatitis B: efficacy and breakthroughs (2001) (2)
- A Review of HDV Infection (2022) (2)
- 73 WORLDWIDE EXPERIENCE TREATING CHRONIC HEPATITIS C (CHC) WITH PEGINTERFERON ALFA/RIBAVIRIN: FINAL RESULTS FROM 7163 NAIVE, MONO-INFECTED PATIENTS ENROLLED IN THE LARGE MULTINATIONAL PROPHESYS COHORT STUDY (2012) (2)
- Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study (2006) (2)
- Definition of hepatitis B infection for the best practice in chronic disease and in immunosuppressed patients. (2008) (2)
- Clinical and virological course of multiple viral infections (HBV, HDV, HCV) after liver transplantation (2001) (1)
- Helicobacter pylori infection and coronary heart disease: a continuously debated question. (2001) (1)
- [Epidemiology of lesions caused by non-steroidal anti-inflammatory agents]. (1992) (1)
- 219 Angiotensin II type 1 receptor inhibition in early stage cirrhotic patients: Effects on portal pressure and liver fibrosis (2004) (1)
- THU-208-Characterization of a novel chemiluminescent enzyme immunoassay for the quantitation of antibodies to hepatitis B core antigen class IgG and correlation with intrahepatic HBV covalently-closed-circular DNA (2019) (1)
- The colonosight®, a new colonoscope with disposable capabilities, no fiber optics and a pull-power assisted engine leads to major advances in colonoscopic technology (2006) (1)
- Markedly improvement of glycaemic control in diabetic patients with chronic hepatitis C achieving sustained virologic response after direct acting antiviral therapy: results of a prospective controlled study (2017) (1)
- Increased expression of renal neutral endopeptidase (EC 3.4.24.11) in rats with CCl4-induced cirrhosis with ascites: acute effects of its pharmacological inhibiton with i.v. Candoxatrilat. (2004) (1)
- Preliminary results of naive combination therapy with 12KDA peg-IFN α-2B and ribavirin in recurrent hepatitis C after liver transplantation (LT) (2003) (1)
- Tu1123 Medical Education in Resource-Limited Regions: Lessons from A National Training Workshop for Liver Disease in Mongolia (2016) (1)
- [Stauffer's syndrome. Report of a clinical case]. (1978) (1)
- P.279 A randomised trial of pegylated interferon alpha-2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin (2006) (1)
- Strategies for the diagnosis of gastro-esophageal reflux disease. (2004) (1)
- 1155 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY (2012) (1)
- A long-term virological follow up in patients treated with orthotopic liver transplantation (OLT) for hepatitis delta virus (HDV) (2001) (1)
- [Delta hepatitis]. (1985) (1)
- Any role for Helicobacter pylori in gastropathies of liver disease? (2006) (1)
- [Lipohyperplasia or intestinal lipomatosis]. (1998) (1)
- Is GVHD a model of PBC? Characterization of autoantibodies in GVHD (1998) (1)
- P1209 FACTORS INFLUENCING RENAL FUNCTION IN PATIENTS RECEIVING TELAPREVIR TWICE DAILY OR EVERY 8 HOURS: RESULTS FROM THE PHASE III OPTIMIZE STUDY (2014) (1)
- Immunohistochemical research of HDV infection in Chinese patients with chronic liver disease. (1990) (1)
- Deep Sedation for Prolonged Endoscopic Procedures in Cirrhotic Patients: Results of a Prospective Controlled Study (2009) (1)
- The hepatitis delta virus and its infection continued. (1987) (1)
- Temporary Placement of the Polyflex Stent for the Treatment of Refractory Benign Esophageal Strictures (2004) (1)
- Long term follow-up after H.pylori eradication: Results of a prospective study (2000) (1)
- F-32 Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: experience from a nosocomial cluster of infection (2013) (1)
- Ineffectiveness of hepatitis B vaccination in lamivudine-treated cirrhotics. (2004) (1)
- An immunofluorescence blocking test to detect antibodies against the hepatitis B delta and core (HBcAg) antigens. (1978) (1)
- OC.11.4: ROLE OF EUS-FNA IN THE DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMORS AND VALUE OF KI-67 EXPRESSION MEASUREMENT ON CYTOLOGICAL SPECIMENS (2011) (1)
- PERFORMANCE AND SAFETY OF A NEW CYTOLOGY BRUSH IN ENDOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION (EUS-FNA): PRELIMINARY EXPERIENCE (2009) (1)
- Antibodies against the human pancreas in acute and chronic liver disease (1975) (1)
- Localization of carcinoembryogenic antigen (CEA) in normal, inflammatory and neoplastic colonic mucosa by immunofluorescence. (1977) (1)
- Epidemiological study of inflammatory bowel diseases in BRA, Piemonte, Italy: Methodological problems (2001) (1)
- Gastro-oesophageal reflux disease and asthma: would be possible to improve therapy on the basis of what is now known? (2004) (1)
- P0364 : Clinic evaluation of circulating micrornas as potential biomarkers of hepatocellular carcinoma in patients with HBV chronic infection (2015) (1)
- Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel? (2022) (1)
- Effect of different doses (1,000,000 or 3,000,000 exits) of alpha-interferon on the ALT level of nonAnonB patients (1989) (1)
- Pegylated 40KDA IFN alfa-2a plus amantadine (AMA) or ribavirin (RBV) in naives with chronic hepatitis C (CHC): the HIMPCT (Hepatitis Italian Multicenter Pegasys Amantadine Cooperative Trial) (2002) (1)
- 1341 IL28B GENOTYPING FOR 2 SNPS ASSOCIATED WITH CHRONIC HEPATITIS C THERAPY RESPONSE (2011) (1)
- Matabolomic analysis identifies new biomarkers of liver damage in NAFLD (2014) (1)
- 371 OUTCOME OF CHRONIC HEPATITIS DELTA IN ITALY: A LONG TERM COHORT STUDY (2009) (1)
- Hepatitis δ virus (HDV) infection and disease (1989) (1)
- In experimental preascitic liver cirrhosis calcium-dependent diuretic systems are downregulated, but may be normalized by specific metabolic and pharmacologic stimuli (2007) (1)
- Glomerular vas efferens vasoconstriction and loss of tubular-glomerular feedback in patients with decompensated non-azotemic cirrhosis (2001) (1)
- 1085 PEG-INTERFERON AND RIBAVIRIN IN HCV-RELATED CIRRHOTIC PATIENTS WITH PROFOUND THROMBOCYTOPENIA (2012) (1)
- Roxithromycin-based therapy for Helicobacter pylori eradication: reply to Dr. Barbon (2009) (1)
- Hepatitis delta virus (HDV) RNA species in liver and serum of patients with chronic type D hepatitis (1989) (1)
- Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: Comparison with propranolol in a randomised controlled study (2001) (1)
- 1365 METABOLIC ALTERATIONS OF LIPID KINETICS IN NAFLD PATIENTS AND THEIR CONTRIBUTION TO LIVER DAMAGE (2013) (1)
- 4756 Eus can supply information of clinical usefulness and prognostic value in evaluating patients with portal hypertension (ph). (2000) (1)
- Hepatocellular carcinoma: screening and therapy. (2000) (1)
- [New strategies for treatment of chronic hepatitis C]. (1999) (1)
- P.255 Long term follow-up of previous hepatitis C virus positive non-responders to interferon monotherapy successfully re-treated with combination therapy: are they really cured? (2006) (1)
- 919 ANEMIA AND ITS MANAGEMENT IN PATIENTS TREATED WITH TELAPREVIR TWICE DAILY VERSUS EVERY 8 HOURS IN THE PHASE III OPTIMIZE STUDY (2013) (1)
- Helicobacter pylori seroprevalence in hepatitis with cirrhosis C virus positive patients (2000) (1)
- P175: Epidemiology and clinical course of hepatitis delta virus infection over 15 years in a liver center in Northern Italy (2015) (1)
- Chapter 32 – Hepatitis D (2012) (1)
- [A case of hepatocarcinoma preceded by several years by "isolated" increase in alphafetoprotein]. (1992) (1)
- Management of Hepatitis B Virus Infection in Liver Transplantation Setting; The Rising Concerns and Growing Hopes, Report From 10th Congress of the Iranian Society for Organ Transplantation, 2011, Shiraz, Iran (2012) (1)
- 843 ADRENAL DYSFUNCTION IN CIRRHOSIS: PREVALENCE AND IMPACT ON SURVIVAL IN NONSEPTIC PATIENTS WITH ASCITES (2010) (1)
- Sorafenib versus Y90-Radioembolization: A preliminary assessment of tolerability and survival in advanced mono-lobar hepatocellular carcinoma (2014) (1)
- Interferon treatment of chronic hepatitis B surface antigen (HBsAg) carriers. A description of the activation profiles of natural killer cells obtained with different schedules of administration in three subsets of carriers (1987) (1)
- Recent results in the treatment of chronic B virus hepatitis. (1995) (1)
- P.1.277: PORTAL VEIN THROMBOSIS IN CIRRHOTIC AND NONCIRRHOTIC PATIENTS. ROLE OF ANTICOAGULATION THERAPY (2011) (1)
- Hepatit is Delta : The Rediscovery (2013) (1)
- [216] MIDODRINE IN THE PREVENTION OF HEPATORENAL SYNDROME TYPE 2 RECURRENCE: A CASE-CONTROL STUDY (2007) (1)
- 4532 Clinical application of endoscopic ultrasound in portal hypertension: eus can predict variceal recurrence in endoscopically treated patients. (2000) (1)
- Methods for detection of the delta antigen and antibody in liver and serum. (1983) (1)
- On infections and ischemic heart diseases. (2007) (1)
- Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication: a retrospective study. (2010) (1)
- Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile. (2015) (1)
- Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study. (2008) (1)
- Sa1136 Poor Screening Rates for HBV, HCV, HDV and Hepatocellular Carcinoma (HCC) and Low Rates of Antiviral Therapy in Mongolia: Results From Survey of Physicians From All Major Provinces of Mongolia (2016) (1)
- Role of endoscopic ultrasound in biliary and unexplained pancreatitis. (2007) (1)
- Efficacy of cefixime plus metronidazole therapy for Helicobacter pylori eradication: a retrospective study. (2013) (1)
- T-01 OPTIMIZE trial: non-inferiority of twice-daily telaprevir versus administration every 8 hours in treatment-naïve, genotype 1 HCV infected patients (2013) (1)
- Predictors of virologic response in combination therapy with interferon (IFN) alfa 2B plus ribavirin of recurrent hepatitis C after liver transplantation (LT) (2003) (1)
- [614] HOST AND VIRAL BASELINE CHARACTERISTICS IN HEPATITIS C NAIVE AND NON-RESPONDER PATIENTS: COMPARISON OF THREE LARGE RANDOMISED MULTINATIONAL TRIALS (2007) (1)
- P.03.8 PEG-IFN FOR CHRONIC HEPATITIS C IN CLINICAL PRACTICE: THE PROSPECTIVE PHASE OF THE AIFA STUDY (2012) (1)
- Use of corticosteroids, immunomodulators, and infliximab at a third-level Day-Hospital Service of Gastro-Hepatology. (2008) (1)
- Occult hepatitis B virus infection in HBS antigen-negative patients undergoing liver transplantation for end-stage liver disease (2003) (1)
- [Screening for hepatocellular carcinoma]. (2005) (1)
- Letter: renal effects of tenofovir in adefovir dipivoxil‐experienced HBV patients (2014) (1)
- Role of coinfection by transfusion-transmitted virus (TTV) in patients with chronic HCV hepatitis. (1999) (1)
- Feasibility and diagnostic accuracy of K-RAS mutation analysis in fine needle aspirate under EUS guidance of pancreatic masses (2010) (1)
- P183: Liver transplantation for hepatitis B with delta coinfection: a single center experience (2015) (1)
- 229 GLUTEN/CASEIN-FREE DIET AND LIVER ENCEPHALOPATY (2009) (1)
- Review Hepatitis D: Thirty years after q (2009) (1)
- Sa1637 High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin Among Patients With Decompensated Cirrhosis Who Underwent Liver Transplant During Participation in the SOLAR-1 and SOLAR-2 Studies (2016) (1)
- Distribution of antibodies against the delta-antigen in HBsAg carriers detected by a simple immunofluorescence blocking test. (1978) (1)
- Low rates of screening and treatment of chronic hepatitis B, C, D (HBV, HCV, HDV), and hepatocellular carcinoma (HCC), associated barriers, and proposed solutions: results of a survey of physicians from all major provinces of Mongolia (2016) (1)
- Negative predictive value of endoscopic ultrasound in patients referred for fine-needle aspiration. (2011) (1)
- Different contribution of metabolic and viral steatosis to liver damage (2005) (1)
- Immunoblotting for the hepatitis delta antigen: diagnostic role. (1991) (1)
- 494 Two-state modeling of virological and biochemical efficacy plus liver biopsies demonstrate efficacy of adefovir dipivoxil in HBeAg-negative chronic hepatitis B over four or five years (2006) (1)
- Systemic Virosis Producing Hepatitis (2008) (1)
- P7: Daclatasvir + sofosbuvir with or without ribavirin in patients with chronic HCV infection: interim analysis of a multicenter compassionate use program (2014) (1)
- A PCR analysis of reinfection and liver disease in liver transplant (OLT) due to hepatitis viruses (1991) (1)
- Serum heat shock protein 27 levels in patients with hepatocellular carcinoma (2012) (1)
- [Abdominal pain and bowel dysfunction: diagnostic flow-chart could be simplified?]. (2001) (1)
- Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification (2022) (1)
- Rescue with infliximab and surgical outcomes for refractory ulcerative colitis. (2007) (1)
- Histopathology of recurrent delta hepatitis in liver transplant. (1993) (1)
- Liver damage can be associated with deregulation of the de novo lipogenesis pathway in subjects with Non Alcoholic Fatty Liver Disease (2015) (0)
- Infection with thedelta agent inchildren (2011) (0)
- P917 PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE (2014) (0)
- [Treatment of chronic viral hepatitis with interferon]. (1988) (0)
- IL28B rs12979860 CC Genotype, Metabolic Profile and SVR in Patients with Genotype 1 Chronic Hepatitis C. (2012) (0)
- Metabolic syndrome (MS) in non-alcoholic fatty liver disease (NAFLD) (2003) (0)
- EUS-guided cytologic diagnosis of pancreatic endocrine tumors: Immunocytochemical features and the impact of on-site cytopathological assessment (2011) (0)
- Identification of HBV-DNA markers that are predictive of response to lamivudine therapy in patients infected with HBV precore variants (2003) (0)
- 257 SORAFENIB VERSUS RADIOEMBOLIZATION WITH Y90: CLINICAL EVALUATION AND SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA AND CIRRHOSIS (2013) (0)
- P.07.5 INCIDENCE OF MICROANGIOPATHY IN PATIENTS WITH CHRONIC HEPATITIS C AND TYPE 2 DIABETES MELLITUS: RESULTS OF A PROSPECTIVE CONTROLLED COHORT STUDY (2014) (0)
- P1042 : Deregulation of de novo lipogenesis can be associated with liver damage in patients with non alcoholic fatty liver disease (2015) (0)
- News and notices (2005) (0)
- Individualized treatment of chronic hepatitis C: from research to clinical practice. (2006) (0)
- Safety and efficacy of sofosbuvir-based antiviral therapy immediately after liver transplantation: A matched case–control analysis (2016) (0)
- 118 KEY ROLE OF CHYMASE IN THE HEPATIC PRODUCTION OF ANGIOTENSIN II AND IN THE DEVELOPMENT OF EXPERIMENTAL LIVER CIRRHOSIS AND ITS COMPLICATIONS (2012) (0)
- Detection of nuclear oncoproteins in liver biosies from patients with chronic liver disease: An immunofluorescence (IFL) study (1991) (0)
- La terapia dell’epatite cronica C: un problema (quasi) risolto (2014) (0)
- [The letter of discharge from hospital of a patient with liver cirrhosis]. (2001) (0)
- 24 Occult hepatitis B virus infection in HBs antigen-negative patients undergoing liver transplantation for end-stage liver disease (2003) (0)
- From Here to 1996 (1994) (0)
- Discordant results for IL28B genotyping (rs12979860 vs. rs8099917) and the prediction of rapid viral response inchronic hepatitis C (2012) (0)
- Prognostic factors after resection of hepatocellular carcinoma (HCC) in cirrhosis (1989) (0)
- P0060 : Antiviral therapy with sofosbuvir plus ribavirin in HCV-infected cirrhotic patients awaiting liver transplantation: Preliminary data from a single-centre experience (2015) (0)
- Toxicity of azathioprine (AZA) in cyclosporine (CsA) responsive ulcerative colitis (UC) (2000) (0)
- Hemorrhoidal rubber band ligation with a variceal multi-band device (2001) (0)
- P.1.245: FUNCTIONAL DYSPEPSIA: OCTANOIC ACID BREATH TEST EVALUATION AND TREATMENT WITH BUSPIRONE (2011) (0)
- 820 HCV GENOTYPE 4 IN SUBJECTS UNDERGOING ANTIVIRAL TREATMENT IN ITALY (2008) (0)
- Covered ultraflex stent for recanalization of an obstructed enteral wallstent placed through a malignant esophago-jejunal stricture (2001) (0)
- INHIBITION OF HEPATITIS C VIRUS TRANSLATION AND SUBGENOMIC REPLICATION BY SMALL INTERFERING RNAS DIRECTED AGAINST CELLULAR RNA BINDING PROTEINS (2004) (0)
- LIST OF ABBREVIATIONS: LB: liver biopsy NAFLD: Non-Alcoholic Fatty Liver Disease US: ultrasound NASH: Non-Alcoholic Steatohepatitis NISF: Non-Invasive Score system for Fibrosis CH: chronic viral hepatitis LSM: Liver Stiffness Measurement ICC: Intraclass Correlation Coefficient S4: diameter of hepati (2014) (0)
- Molecular signatures reveal a novel HLA-B(star)15-restricted CD8 T cell epitope on the large hepatitis delta antigen (2015) (0)
- Systemic nitric oxide production: A mechanism supporting the glomerular filtration rate in non-azotemic human cirrhosis? (2001) (0)
- PNPLA3 gene variants and insulin resistance in patients with genotype-1 chronic hepatitis C (2013) (0)
- 8 P Low systemic angiotensin converting enzyme (ACE) plasma levels a critical factor leading to functional renal failure in patients with decompensated liver cirrhosis (2002) (0)
- Analysis of hemodynamic effects of bosentan on portopulmonary hypertension in short-term and medium-term follow-up: Promising predictors of response to therapy? (2016) (0)
- Immunofluorescence detection ofnewantigen- antibody system (S/anti-5) associated tohepatitis B virus inliver andinserumofHBsAgcarriers (1977) (0)
- 321 Safety and Efficacy of 96 Weeks of Tenofovir Disoproxil Fumarate Therapy in Lamivudine Experienced Patients (2009) (0)
- Diversity of clinical presentation and virological characteristics of hepatitis delta: The hepatitis Delta International network (HDIN) (2016) (0)
- Anti-hepatitis C virus in nonAnonB patients responding and non-responding to alpha-2A interferon (1989) (0)
- Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma (2009) (0)
- Progress in the prevention and control of viral hepatitis type B (2002) (0)
- [Chronic diarrhea: a difficult diagnosis. A rare cause: lymphocytic colitis]. (1997) (0)
- P9: Efficacy and safety of simeprevir in treatment naïve HCV genotype 1‐infected patients with METAVIR F2 fibrosis: QUEST‐1 and QUEST‐2 Phase III studies (2014) (0)
- Management of duodenal ulcer disease in the era of H. pylori. (1999) (0)
- P.1.116: INTRAJEJUNAL ADMINISTRATION OF DUODOPA IN PATIENTS WITH PARKINSON'S DISEASE: ENDOSCOPIC PROCEDURE AND COMPLICATIONS (2011) (0)
- Two discrete populations of patients with steroid-unresponsive ulcerative colitis (UC) identified by their indication to receive oral cyclosporin (CsA)and equally responsive to it (2000) (0)
- Subtypes of specialized intestinal metaplasia (SIM) and risk of adenocarcinoma in long-segment Barrett: results of a prospective study (2000) (0)
- [Post-transfusion infection by the delta hepatitis virus]. (1985) (0)
- Oxidative Stress and Cell Damage Following Orthotopic Liver Transplantation. (1996) (0)
- Cost-effectiveness of capsule enteroscopy in patients with obscure GI bleeding: A multicenter study (2006) (0)
- [Adult human liver cells grown in a culture media containing a transforming factor similar to epidermal growth factor]. (1985) (0)
- P.14.7 FEASIBILITY AND DIAGNOSTIC YIELD OF A NEW EUS HISTOLOGY NEEDLE: COMPARISON WITH STANDARD EUS-GUIDED FNA (2012) (0)
- Anticomplementary Activity and Complementemia in Patients with Chronic Liver Disease (1976) (0)
- T.N.26 TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) FOR HEPATOCELLULAR CARCINOMA IN CIRRHOSIS: INFLUENCE ON PORTAL HYPERTENSION (2010) (0)
- CHRONIC DELTA INFECTION IN ITALY - ANALYSIS OF GENOTYPES (1994) (0)
- 700 RISK OF HEPATITIS B AND EFFICACY OF TREATMENT WITH LAMIVUDINE IN PATIENTS UNDERGOING ALLO-SCT (2008) (0)
- P1058 : Increased epicardial fat and early signs of impaired diastolic and systolic left ventricular function in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic Fatty Liver Disease (2015) (0)
- Barrett's esophagus and ineffective esophageal motility (IEM) (2000) (0)
- The kit receptor as a marker of neoplastic progression in Barrett's esophagus (2001) (0)
- 13 P Palliation of malignant upper gastrointestinal obstruction using two different types of metal stent (2002) (0)
- Retreatment and Long-Term Therapy with Peginterferon: the HALT-C, EPIC3 and COPILOT Studies (2006) (0)
- Spectral-EEG analysis in hepatic encephalopathy before and after liver transplantation (LT) (2001) (0)
- Response to azathioprine therapy in Crohn's disease: A logistic regression model (2000) (0)
- P.08.9 A PILOT STUDY ON MICROWAVE PERCUTANEOUS ABLATION OF MEDIUM-SIZED HEPATOCELLULAR CARCINOMA: A TWO YEARS FOLLOW-UP EXPERIENCE (2012) (0)
- Clinical evaluation of circulating microRNAs as potential biomarkers of hepatocellular carcinoma in patients with chronic HBV infection (2015) (0)
- Combined immunomodulatory treatment for steroid- resistant ulcerative colitis (UC): a 9-year experience at a single center (2000) (0)
- [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations]. (2007) (0)
- 4757 Role of endoscopic ultrasonography in therapeutic decision making and in following-up gastrointestinal submucosal tumors and extraluminal compressions. (2000) (0)
- 36 PS Radioferquency energy delivery (stretta procedure) for the treatment of gastro-oesophageal reflux disease: Preliminary data (2002) (0)
- ANTIVIRAL THERAPY WITH SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE (2015) (0)
- Digestive endocopy and risk of hepatitis C virus transmission: Results of a retrospective study among blood donors (2001) (0)
- Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial. (1989) (0)
- Low liver disease screening and treatment rates in Mongolia: results from a physician survey (2016) (0)
- Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease (2014) (0)
- Management strategies in resection for carcinoma of the hepatic duct confluence: how to increase the resectability rate. Our experience and literature review. (2000) (0)
- Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen levels in the natural history of chronic HBV infection (2018) (0)
- A randomized controlled trial of metformin vs. vitamin E or prescriptive diet in Non Alcoholic Fatty Liver Disease (2005) (0)
- F-37 Sorafenib versus 90Y-radioembolization: a preliminary study on tolerability and survival in patients with advanced mono-lobar hepatocellular carcinoma (2013) (0)
- Hepatitis D virus in Uzbekistan. (2020) (0)
- 60 Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and HCV chronic hepatitis (2004) (0)
- 10 Liver transplantation for recently detected hepatocellular carcinoma (2000) (0)
- [Tissue genes: the application of hybridization in situ in hepatology]. (1995) (0)
- A Novel Approach for Hepatitis Delta Virus Viremia Quantification by Droplet Digital PCR Assay (2016) (0)
- Molecular defects in two genetic disorders of iron recycling: aceruloplasminemia and hemochromatosis type 4 (2002) (0)
- T.N.7 MULTIPLE CYCLES OF G-CSF ADMINISTRATION TO MOBILIZE BONE MARROW-DERIVED CELLS (BMC) IN PATIENTS WITH END STAGE LIVER CIRRHOSIS (2010) (0)
- Risk of Hepatitis B and Efficacy of Treatment with Lamivudine in Patients Undergoing Allogeneic Stem Cell Transplant. (2007) (0)
- Mo1425 The New Cito-Histologic Needle in Comparison With Standard EUS-Fine Needle Aspiration: Diagnostic Yield and Safety Profile in Our 2-Years Experience (2014) (0)
- [Chronic hepatitis: diagnostic and therapeutic problems]. (1975) (0)
- Autoimmunity in interferon treated patients with viral chronic liver disease of diffferent etiology (1989) (0)
- Free Paper Session I (2006) (0)
- Effects of candoxatrilat, a neutral endopeptidase inhibitor, on sodium and free water urinary excretion in the rat model of CcI4-induced cirrhosis with ascites (2003) (0)
- The hepatitis delta virus. Proceedings of the Third International Symposium on Hepatitis Delta Virus. Washington, D.C., October 26-28, 1989. (1990) (0)
- V.02.7 INCIDENTAL ENDOSONOGRAPHIC FINDING OF AN INTRA-CARDIAC MASS IN AN ASYMPTOMATIC PATIENT (VIDEO) (2014) (0)
- P.085 Short treatment schedule may be effective in rapid viral responders to peg-interferon plus ribavirin for genotype 1 chronic hepatitis C (2006) (0)
- OC-17 Portopulmonary hypertension treatment in orthotopic liver transplantation era (2013) (0)
- 30 OC Ciprofloxacin versus mesalazine in the prevention of postoperative recurrence of Crohn's disease: Preliminary results (2002) (0)
- Is the control of renal sodium excretion by circulating aldosterone completely clarified in patients with liver cirrhosis without functional renal failure (2000) (0)
- UCTN – Unusual cases and technical notesE 94 (2011) (0)
- A radioimmunoassay for HBcAg in the sera of HBsAg carriers: serum HBcAg, liver HBcAg immunofluorescence as markers of chronic liver disease. (1981) (0)
- Focal intrahepatic storage of oligomannosides mimicking a primitive liver neoplasm. (2001) (0)
- F.N.5 ADRENAL DYSFUNCTION IN CIRRHOSIS: PREVALENCE AND IMPACT ON SURVIVAL IN NONSEPTIC PATIENTS WITH ASCITES (2010) (0)
- Inappropriately low angiotensin II generation: A factor determining impaired renal function and reduced survival in patients with decompensated liver cirrhosis (2003) (0)
- 46 Identifying with widened criteria a graft suitable for transplant (2000) (0)
- Su2053 Long-Term Clinical Outcomes of Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤3 CM (2012) (0)
- HBV replication influences the course of chronic hepatitis D (1991) (0)
- 168 Thromboelastogram changes in the perioperative period of adult living liver donation (2004) (0)
- Incidence of p53 gene mutations in 93 consecutive long-segment Barrett's patients (2001) (0)
- A 2010 panorama on diseases of the small and large intestine. (2010) (0)
- 29 OP Clinical usefulness of intraductal ultrasonography in patients with biliary stenosis of unknown origin (2002) (0)
- Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation (2023) (0)
- Treatment with interferon-α2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study (2001) (0)
- P1158 EFFICACY AND SAFETY OF BOCEPREVIR-BASED THERAPY IN HCVG1 TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED FIBROSIS/CIRRHOSIS: THE ITALIAN AND SPANISH NPP EARLY ACCESS PROGRAM (2014) (0)
- P.1.334: MICROSCOPIC COLITIS IN PATIENTS WITH MARSH I-II: A NEW CLINICAL AND PATHOLOGICAL ENTITY? (2011) (0)
- P.1.211: DIAGNOSTIC YIELD OF EUS-FNA IN THE DIAGNOSIS OF SUBEPITHELIAL LESIONS OF THE GASTROINTESTINAL TRACT (2011) (0)
- Prevalence of inflammatory bowel diseases in BRA, Piemonte, Italy (2001) (0)
- OC.17.4 FEASIBILITY AND DIAGNOSTIC YIELD OF A NEW EUS CITO-HISTOLOGIC NEEDLE IN COMPARISON WITH STANDARD EUS-FINE NEEDLE ASPIRATION: A 2-YEAR SINGLE-CENTRE EXPERIENCE (2014) (0)
- Admission to a gastroenterology unit for adverse drug reactions (2006) (0)
- [IgM type antibodies against delta hepatitis virus: qualitative analysis]. (1986) (0)
- Contents Vol. 18, 2001 (2001) (0)
- Rapidly progressive HBsAg hepatitis in Italy: a syndrome of Delta hepatitis virus superinfection (1986) (0)
- Treatment prioritization according to the EASL HCV CPG 2015: a real-life evaluation on the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort (2015) (0)
- [Gastroenterologists in ambulatory care. The experience in Turin in the year 2000]. (2001) (0)
- When is acute pancreatitis related to ERCP predictable (1998) (0)
- Chapter 33 – Hepatitis D (2006) (0)
- Polycystic liver disease (2001) (0)
- Antiviral therapy with sofosbuvir plus ribavirin for the treatment of severe HCV recurrence after liver transplantation: preliminary data from a single-centre experience (2015) (0)
- Feasibility and efficacy of sofosbuvir-based antiviral therapy before liver transplantation to prevent HCV recurrence: A monocentric experience (2016) (0)
- Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy. (2015) (0)
- P1056 : Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in patients with nonalcoholic fatty liver disease, independently of diabetes, hypertension and dyslipidemia (2015) (0)
- Hepatic iron burden in nonalcoholic steatohepatids (NASH): etiologic associations and impact on liver damage (2002) (0)
- Accumulation of a cellular protein bearing c-myc-like antigenicity in hepatic and non-hepatic delta antigen expressing cells. (1993) (0)
- F-15 Regression of cirrhosis by hepatic venous pressure gradient (HVPG) measurement in long-term responders to anti-HBV therapy (2013) (0)
- P1028 NON-INVASIVE SCORE SYSTEM FOR FIBROSIS (NISF) IN CHRONIC LIVER DISEASE: A NEW MODEL COMBINING BIOCHEMICAL, ELASTOGRAPHIC AND ULTRASOUND DATA (2014) (0)
- [Anesthesia for cesarean section. Ketamine-neuroleptoanalgesia combination]. (1977) (0)
- Virologia,patogenesi e diagnostica dell'infezione Delta (1993) (0)
- Evidence of post-glomerular arterial vasoconstriction as a mechanism preserving glomerular filtration rate in patients with cirrhosis and recent ascites development (2000) (0)
- [Anatoma-clinical correlations in patients with liver diseases with circulating antibodies studied in regional case records]. (1976) (0)
- 338 Hepatic chimerism in patients with gender-mismatch liver transplantation (2004) (0)
- OC.09.7: PEG-IFN FOR HEPATITIS C IN CLINICAL PRACTICE: RESULTS OF THE RETROSPECTIVE PHASE OF THE AIFA STUDY (2011) (0)
- 1088 RATES AND PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE AND RELAPSE IN ITALIAN NAIVE MONO-INFECTED CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON ALFA/RIBAVIRIN: PROPHESYS 2 FINAL ANALYSIS (2012) (0)
- [Chronic viral hepatitis: when interferon does not work]. (1995) (0)
- Prevalence of hepatitis C virus/hepatitis G virus co-infection in Turin: updated data ten years later. (2008) (0)
- P1187 A CONCENTRATION-DEPENDENT PHARMACOKINETIC INTERACTION WITH TELAPREVIR INCREASES RIBAVIRIN CONCENTRATIONS AND LEADS TO HIGHER HAEMOGLOBIN DROP (2014) (0)
- Screening for coeliac disease in women with recurrent spontaneous abortion sine causa. (2000) (0)
- Metabolic Syndrome after liver transplantation: have risk factors changed over time? (2015) (0)
- Incidence of Type 2 diabetes mellitus and glucose abnormalities in treated patients with chronic hepatitis C infection: results of a controlled follow-up study. (2007) (0)
- 103 RELATIVE ADRENAL INSUFFICIENCY IN CIRRHOSIS: RELEVANCE IN PATIENTS WITH ASCITES AND TREATMENT WITH HYDROCORTISONE IN REFRACTORY ASCITES (2009) (0)
- Controversies Regarding the Hepatitis B Immune Globulin Prophylaxis (HBIG) for Liver Transplantation Recipients (2014) (0)
- Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic fatty Liver Disease (2015) (0)
- Endosonographic findings can predict variceal recurrence in patients with endoscopic eradication of oesophageal varices (2000) (0)
- Azathioprine (AZA) limits endoscopic recrudescence of cyclosporine (CsA)-responsive ulcerative colitis (UC) (2000) (0)
- Antiviral treatment discontinuation among hepatitis C‐infected individuals with thrombocytopenia (2015) (0)
- Effect of leukocyte apheresis on oxidative stress and fibrosis in inflammatory bowel diseases (2008) (0)
- Chronic Infection with the Hepatitis Delta Virus (1986) (0)
- Fibring glue injection into the submucosa prior to EMR. An experimental study to evaluate different injection techniques (2006) (0)
- Clinical Types of Hepatitis B (1992) (0)
- 9 P A randomised 4-arm multicentre trial of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy (2002) (0)
- The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia (2014) (0)
- Does genotype affect the course of HCV infection (1995) (0)
- Spontaneous seroconversion from HBeAg to anti-HBe is preceded and heralded by a progressive. Increase of 2′,5′-oligoadenylate (2′,5′-OAS) activity (1989) (0)
- P.02.7 EVALUATION OF TPMT GENOTYPE IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH THIOPURINE (2013) (0)
- Abdominal pain and bowel dysfunction: Is it possible a simplified diagnostic flow-chart? (2001) (0)
- Gastric cancer: from Napoleon's death to the early 2011. (2011) (0)
- LIVER TRANSPLANTATION FOR RECENTLY DETECTED HEPATOCELLULAR CARCINOMA.: Abstract# 768 Poster Board #‐Session: P25‐III (2000) (0)
- [Hepatitis E virus: a new infective agent for an old disease]. (1995) (0)
- Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic CHC patients (2009) (0)
- Subject Index Vol. 18, 2001 (2002) (0)
- Long-Term HDV-RNA Suppression - HBsAg Clearance in Chronic Hepatitis D Following Interferon Therapy (2014) (0)
- Complicanze in ecoendoscopia (2004) (0)
- The Hepatitis delta virus and its infection : proceedings of an international symposium on hepatitis delta virus held in Saint Vincent, Italy, June 19 to 20, 1986 (1987) (0)
- P845 IMPACT OF FAT VERSUS GLUCOSE LOAD ON OXIDATIVE STRESS IN NON-ALCOHOLIC FATTY LIVER DISEASE (2014) (0)
- [141] LONG TERM FOLLOW-UP OF LIVER TRANSPLANTATION (OLT) FOR CHOLESTATIC AND AUTOIMMUNE END STAGE LIVER DISEASES (2007) (0)
- P1078 PREDICTION OF EVS PRESENCE BY CALCULATED RISK SCORES IN B-VIRAL CIRRHOSIS (2014) (0)
- Prevalence of Helicobacter pylori infection in patients at diagnosis of inflammatory bowel disease (IBD) (2000) (0)
- Physiopathological role of neutral endopeptidase system (EC3.4.24.11) in liver cirrhosis (2006) (0)
- P.1.346: GRANULOMONOCITAPHERESIS IN CROHN'S DISEASE: PROSPECTIVE STUDY ON CLINICAL EFFICACY (2011) (0)
- P182: Development of a hepatitis delta virus screening method (2015) (0)
- Endoscopic mucosectomy of granular cell tumors of the esophagus (2000) (0)
- Morphological Patterns of HBAg in Chronic Hepatitis (1976) (0)
- [Hepatitis C therapy: a problem almost solved]. (2014) (0)
- [Recurring duodenal ulcer. Evaluation of previous complications as a predictive factor of ulcer recurrence after eradication of Helicobacter pylori]. (1997) (0)
- Differential histological diagnosis of ground glass cells by trichrome staining. (1977) (0)
- 17 Inappropriately low angiotensin II production: A factor determining impaired renal function and reduced survival in patients with decompensated liver cirrhosis (2003) (0)
- Viral hepatitis and delta infection. Proceedings of an International Symposium on Viral Hepatitis. June 10-11, 1983, Torino, Italy. (1983) (0)
- Mo1471 Diagnosis and KI-67 Grading of Pancreatic Neuroendocrine Tumors (pNETs): Role and Accuracy of Endoscopic Ultrasound-Fine Needle Aspiration (EUS-FNA) (2014) (0)
- Hepatocellular carcinoma at the cutting edge of science and practice. (2010) (0)
- 34 P CAP-assisted mucosectomy for early lesions of the upper G1 tract (2002) (0)
- Relationship between HBV core-promoter sequences and selection of lamivudine resistant mutants in CHBe antigen-negative patients (2002) (0)
- Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment. (2011) (0)
- 3D cholangio-Magnetic Resonance Imaging in Caroli disease (2011) (0)
- T-28 Hypothalamic-pituitary-adrenal axis and adrenal dysfunction in non-septic cirrhotic patients with ascites: a pathophysiological and clinical evaluation (2013) (0)
- [Organisation of work teams at the gastroentero-hepatology outpatients clinic. The management of inflammatory bowel diseases]. (2002) (0)
- Evidences for a dynamic aldosteron-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis (2001) (0)
- Prognostic indicators for complications after surgery in Crohn's disease (2000) (0)
- P.03.2 USEFULNESS OF INTRADUCTAL ULTRASOUND (IDUS) IN THE SECOND-LEVEL EVALUATION OF THE BILIARY AND AMPULLARY STENOSES (2014) (0)
- Assessment of intraductal ultrasonography (IDUS) in patients with biliary stenosis of unknown origin (2006) (0)
- 866 DUCTULAR REACTION IS AN INDEPENDENT PREDICTOR OF ADVANCED FIBROSIS IN NAFLD (2011) (0)
- Quantification of serum HDV RNA by ddPCR (2019) (0)
- 29. Treatment of Hepatitis D (2013) (0)
- Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test. (1984) (0)
- Rate response to Azathioprine in ulcerative colitis (UC) (2000) (0)
- [Cyclosporin for steroid refractory ulcerative colitis. Results of a study conducted at Turin General Hospital between 1990 and 1997]. (1998) (0)
- Hepatitis B therapy, hepatocellular carcinoma and HBsAg mutants. (2013) (0)
- Diagnostic accuracy and clinical utility of K-ras mutation analysis on FNA aspirates of pancreatic masses under EUS guidance (2011) (0)
- SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH SEVERE HCV RECURRENCE AFTER LIVER TRANSPLANTATION: A SINGLE CENTRE EXPERIENCE (2015) (0)
- Clinical and virological course of multiple viral infections after liver transplantation. (2001) (0)
- Efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation at risk of hepatis B virus reactivation (2010) (0)
- 27 PORTOPULMONARY HYPERTENSION TREATMENT IN ORTHOTOPIC LIVER TRANSPLANTATION ERA (2013) (0)
- Diagnostic value of different antiliver/kidney microsome antibodies (1985) (0)
- P0519 : Lipidomics reveals that low plasma unsaturated to saturated fat ratios are biomarkers of NAFLD and liver damage (2015) (0)
- Increased LDL-cholesterol susceptibility to oxidation contributes to oxidative damage in non alcoholic steatohepadtis (NASH) (2002) (0)
- Metabolic significance of hepatic steatosis in non alcoholic fatty liver disease and chronic hepatitis C. (2008) (0)
- 45 IMMUNE EVASION OF HEPATITIS DELTA FROM CD8+ T CELL IMMUNE RESPONSE (2013) (0)
- P843 ALTERATION IN GLUCOSE METABOLISM AFTER AN ORAL GLUCOSE LOAD AND RELATIONSHIP WITH LIVER DAMAGE IN PATIENTS WITH NAFLD (2014) (0)
- Safety and efficacy of twice daily versus every 8 hour telaprevir with Peginterfepon/Ribavirin (PR) in patients with cirrhosis (2013) (0)
- Application Of Nucleic acid hybridization to the hepatitis δ virus research (1988) (0)
- HCV and TTV Co-infection in Turin, Italy (2009) (0)
- c-myc expression in cells infected with hepatitis delta virus. (1993) (0)
- 519 Long-term occurrence of liver complications in hepatitis C patients. Association with host and viral factors (2004) (0)
- Retreatment with pegylated interferon alfa-2B plus ribavirin with or without amantadine of patients with chronic hepatitis C relapsing after standard interferon and ribavirin: Results of a randomized controlled trial (2006) (0)
- 679 INHIBITION OF CHYMASE-DEPENDENT PRODUCTION OF KIDNEY ANGIOTENSIN II IMPROVES RENAL SODIUM HANDLING AND PREVENTS ASCITES IN EXPERIMENTAL LIVER CIRRHOSIS (2012) (0)
- 764 ABNORMAL SYSTEMIC BIOMOLECULAR EXPRESSION OF CALCIUM-SENSING RECEPTORS (CARS) IN CIRRHOTIC RATS: A NEW MECHANISM OF DISEASE IN PORTAL HYPERTENSION (2009) (0)
- 766 NEUTRAL ENDOPEPTIDASE (EC 3.4.24.11) INHIBITION BLUNTS ENDOTHELIN-1 PRODUCTION IN CIRRHOTIC RAT LIVERS: PHYSIOPATHOLOGICAL IMPLICATIONS (2007) (0)
- P.11.11 HELICOBACTER PYLORI IN CELIAC DISEASE AND IN DUODENAL INTRAEPITHELIAL LYMPHOCYTOSIS: A RETROSPECTIVE STUDY (2012) (0)
- P0063 : Sofosbuvir plus ribavirin for the treatment of severe hcv recurrence after liver transplantation: Preliminary data from a single-centre experience (2015) (0)
- F-14 Hypophosphatemia in Caucasian HBV patients treated with tenofovir is influenced by previous adefovir treatement (2013) (0)
- 14 Hormonal and renal effects of candoxatrilat, a neutral endopeptidase inhibitor, in the rat model of CCL4-induced cirrhosis with ascites (2003) (0)
- 492 ENDOSCOPIC MANAGEMENT OF POST-LIVER- TRANSPLANT BILIARY COMPLICATIONS (2009) (0)
- Association of ITPA polymorphisms instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. (2016) (0)
- [Chronic hepatitis B: standard of therapy and perspectives]. (2016) (0)
- Autoimmune Manifestations in patients with chronic hepatitis and Human Immunodeficiency (HIV) infection (1993) (0)
- Systemic nitric oxide production as a potential mechanism of maintenance of the glomerular filtration rate in non-azotemic human cirrhosis (2000) (0)
- Delta hepatitis. (1988) (0)
- 925 IL28B GENE VARIANTS AND METABOLIC PROFILE IN PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C (2012) (0)
- MiRNome profiling of circulating extracellular vesicles in patients with chronic hepatitis delta treated with pegylated interferon alpha (2022) (0)
- 3 P Prophylaxis of HBV recurrence after liver transplantation in HBsAg-carriers. HBIG and lamivudine theraphy vs HBIG monotheraphy (2002) (0)
- P181: Generation of a cell line that supports the full lifecycle of Hepatitis Delta Virus (2015) (0)
- Loss of tubular-glomerular feedback as a further mechanism of sodiumretention during posture in preascitic liver cirrhosis (2000) (0)
- [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis]. (1995) (0)
- Esophageal expression of the receptor/ligand system (c-kit/SCF) in Barrett's esophagus and esophagitis is associated with acid reflux (2001) (0)
- 22 BIOMOLECULAR EXPRESSION OF TARGET RECEPTORS OF CALCIMIMETIC AGENTS IN EXPERIMENTAL LIVER CIRRHOSIS: A NEW STRATEGY TO REDUCE PORTAL PRESSURE (2010) (0)
- P8: Simeprevir with PegIFN/ribavirin for chronic HCV infection shortens time with patientreported symptoms and impairment in QoL: ATTAIN study results (2014) (0)
- 29 P Postoperative recurrence of Crohn's disease in a mesalazine-treated group of patients (2002) (0)
- Temporary use of a new self-expandable, polyester stent for the treatment of benign esophageal and colonic strictures (2001) (0)
- Perforating Crohn's disease is more aggressive: Further evidence (2000) (0)
- Liver, Pancreas and Biliary Tract O still a typical complication of primary biliary cirrhosis? (2003) (0)
- Prediction of EVS presence by calculated risk scores in B—Viral cirrhosis (2014) (0)
- Cyanoacrylate in the treatment of nonvariceal bleeding of upper digestive tract (1998) (0)
- Human B immunoglobuline (HBIG) monotherapy or combined with lamivudine (LAM) in prophylaxis of HBV recurrence after liver transplantation (LT) in HBsAg-carriers (2002) (0)
- P.02.22 FECAL CALPROTECTIN IS AN EFFECTIVE DIAGNOSTIC TOOL THAT DIFFERENTIATES PATHOLOGICAL FROM FUNCTIONAL INTESTINAL DISORDERS (2013) (0)
- 10 HBV-DNA markers predictive of response to lamivudine (LAM) therapy in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (2003) (0)
- Yearly surveillance and EMR for HGD cases can prevent development of invasive cancer in Barrett's patients: A 5-year prospective study on a large cohort of long-segment Barrett's patients (2006) (0)
- Basal values and on treatment decline of hepatitis B core-related antigen are predictive of response to interferon therapy in patients with chronic hepatitis D (2018) (0)
- Liver transplantation and management of the hepatitis B virus. Preface. (2009) (0)
- Day Bed Unit at the Department of Gastro-enterology. Experience of a study group. (1996) (0)
- P840 ALTERATION IN LIPID METABOLISM AFTER AN ORAL FAT LOAD IN PATIENTS WITH NAFLD (2014) (0)
- 26 PLATELET COUNT/SPLEEN DIAMETER RATIO COMPARED TO HVPG AND TRANSIENT ELASTOGRAPHY TO PREDICT SEVERE PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS (2010) (0)
- Application of nucleic acid hybridization to the hepatitis delta virus research. (1988) (0)
- 826 SAFETY AND EFFICACY OF TWICE DAILY VERSUS EVERY 8 HOUR TELAPREVIR WITH PEGINTERFERON/RIBAVIRIN (PR) IN PATIENTS WITH CIRRHOSIS (2013) (0)
- P174: The cases of intrafamilial transmission of hepatitis delta virus in endemic region (2015) (0)
- 1279 NON-INVASIVE DIAGNOSIS OF NON-ALCOHOLIC STEATOHEPATITIS BY COMBINED CYTOKERATIN-18 APOPTOTIC FRAGMENT AND ELASTOMETRY (2012) (0)
- 196 The mechanisms of sodium and free-water retention in experimental preascitic liver cirrhosis: A physiopathological study (2006) (0)
- Relevance of hepatitis C virus infection in monoclonal gammopathy (1995) (0)
- The influence of liver transplantation (OLT) on antibodies to mitochondria (AMA) and GP210 in primary biliary cirrhosis (PBC) (1997) (0)
- Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: relationship with HBV serum markers (0)
- 471 Long-term follow-up of previous HCV positive non responders to interferon monotherapy successfully retreated with combination therapy (IFN-A2B + ribavirin). Results of a prospective study (2004) (0)
- Epidemiology of the Hepatitis D virus (2020) (0)
- OC.04.2 CYTOLOGY COMBINED WITH FLOW CYTOMETRY (FC) OBTAINED BY EUS-FNA CAN SIGNIFICANTLY IMPROVE THE DIAGNOSIS OF DEEP-SEATED LYMPHOMAS. A RETROSPECTIVE STUDY (2010) (0)
- F-1 IL28B gene variants and metabolic profile in patients with genotype 1 chronic hepatitis C (2012) (0)
- 197 Inappropriately low angiotensin-converting enzyme (ACE) plasma levels: A factor worsening kidney function and survival rate in subsets of patients with decompensated cirrhosis (2004) (0)
- 1134 PREMATURE TREATMENT DISCONTINUATION OF PEG-IFNa-2A/RBV DUE TO GOOD VIRAL RESPONSES AND INSUFFICIENT VIRAL RESPONSES AMONG HCV GENOTYPE 1, 2 AND 3 PATIENTS FROM PROPHESYS (2012) (0)
- PO.21 GLUTEN/CASEIN-FREE DIET IN THE TREATMENT OF CHRONIC LIVER ENCEPHALOPATHY IN PATIENTS WITH SEVERE LIVER CIRRHOSIS (2008) (0)
- Detailed nature of aldosterone-dependent derangement of renal tubular function in nonazotemic human cirrhosis with ascites (2002) (0)
- 346 INCREASED LIVER EXPRESSION OF INFLAMMATORY MEDIATORS IS ASSOCIATED WITH HEPATIC INSULIN RESISTANCE IN LEAN, NON-DIABETIC PATIENTS WITH CHRONIC HEPATITIS C (2009) (0)
- Stereotactic Ablative Radiotherapy in the Treatment of Hepatocellular Carcinoma Lesions Larger than 3 Centimeters (2016) (0)
- Inheritance of low IL-10 and TNF-alpha producing genotypes is associated with a higher risk of liver failure in primary biliary cirrhosis (PBC) (2002) (0)
- Interferon treatment and ALT normalization concomitant with ongoing viral replication (1990) (0)
- Clinical application of endoscopic ultrasonography (EUS) in therapeutic decision making and in following-up gastro-intestinal (GI) submucosal tumors (ST) and extraluminal compressions (EC) (2000) (0)
- 27 P Prognostic value of small bowel thickness 1 year after surgical treatment for Crohn's disease (2002) (0)
- [579] MICROARRAYS ANALYSIS FOR PREDICTING TREATMENT RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C: PRELIMINARY DATA (2007) (0)
- 178 MEGX TEST AND MAYO CLINIC PROGNOSTIC SCORE IN PRIMARY BILIARY CIRRHOSIS (PBC) (1995) (0)
- Non-Invasive Score system for Fibrosis (NISF): A new staging model combining biochemical, elastographic and ultrasound data in chronic liver disease (2014) (0)
- Lack of reinfection after Helicobacter pylori eradication in duodenal ulcer disease: A prospective study from Turin, Italy. (1999) (0)
- Liver Transplantation Interdisciplinary Conference (2) (2009) (0)
- 538 Effects of candoxatrilat, a neutral endopeptidase inhibitor, on sodium and free water urinary excretion in the rat model of CCL4-induced cirrhosis with ascites (2003) (0)
- [LKM (Liver-Kidney-Microsome) antibodies and hepatitis C virus. Description of a clinical case]. (1997) (0)
- 32 Increased expression of renal neutral endopeptidase (EC 3.4.24.11) in rats with CCL4-induced ascitic cirrhosis: Acute effects of its pharmacological inhibition with IV. Candoxatrilat (2004) (0)
- OC1.11.1 HIGH NEGATIVE PREDICTIVE VALUE OF ENDOSCOPIC ULTRASOUND (EUS) IN A COHORT OF PATIENTS REFERRED FOR EUS-GUIDED FINE-NEEDLE ASPIRATION (EUS-FNA) (2008) (0)
- Treatment of HBV Cirrhosis (2012) (0)
- 223 SEDATION FOR ENDOSCOPY IN PATIENTS WITH END- STAGE LIVER DISEASE: RESULTS OF A PROSPECTIVE CONTROLLED STUDY (2009) (0)
- 270 LOW VS STANDARD ALBUMIN DOSAGES IN THE PREVENTION OF PARACENTESIS INDUCED CIRCULATORY DYSFUNCTION: A PRELIMINARY ANALYSIS (2008) (0)
- Diagnosis of deep-seated lymphomas by endoscopic ultrasound guided fine needle aspiration combined with flow cytometric analysis (2011) (0)
- STAT3 signaling pathway: an essential mediator of inflammatory bowel disease and other form of intestinal infiammation (2005) (0)
- Fibrin glue injection with a single lumen standard needle for the hemostasis of bleeding ulcers: A pilot study (2000) (0)
- Cap-assisted endoscopic mucosal resection for neoplastic lesions of the gastrointestinal tract (2001) (0)
- P180: Molecular signatures reveal a novel HLA‐B*15‐restricted CD8 T cell epitope on the large hepatitis delta antigen (2015) (0)
- Ileal adenocarcinoma: Intraoperatory evidence at first diagnosis of Crohn's disease (2000) (0)
- A tailor made anaesthesia: The cerebral state monitor (CSM) and remyfentanil continuous infusion in operative endoscopic ultrasound (EUS) (2006) (0)
- Is there a role for intraductal ultrasonography in clinical practice? Preliminary results from an italian group in patients with biliary stenosis (2001) (0)
- SOFOSBUVIR PLUS RIBAVIRIN BEFORE OR ACROSS LIVER TRANSPLANTATION TO PREVENT HCV RECURRENCE: A SINGLE CENTRE EXPERIENCE (2015) (0)
- Ultrasound evaluation for staging of hepatic fibrosis in patients with chronic liver disease (2008) (0)
- 387 PLATELET COUNT/SPLEEN DIAMETER RATIO COMPARED TO HVPG AND TRANSIENT ELASTOGRAPHY TO PREDICT SEVERE PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS (2010) (0)
- P1120 PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALS (2014) (0)
- Aldosterone-dependent perturbation of renal tubular physiology in non-azotemic human cirrhosis with ascites (2001) (0)
- Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.) Liver Transplantation in Italy: current status (2000) (0)
- [121] IN EXPERIMENTAL PREASCITIC LIVER CIRRHOSIS CALCIUM-DEPENDENT DIURETIC SYSTEMS ARE DOWNREGULATED, BUT MAY BE NORMALIZED BY SPECIFIC METABOLIC AND PHARMACOLOGIC STIMULI (2007) (0)
- News and notices (2005) (0)
- 1351 CONTRIBUTION OF VISCERAL FAT AND HEPATIC FAT TO METABOLIC DERANGEMENTS AND LIVER DAMAGE IN NAFLD PATIENTS (2013) (0)
- Renal tubular electrolyte handing and systemic aldosterone plasma levels in patients with liver cirrhosis without functional renal failure (2001) (0)
- Hepatitis ta virus ( ) infe&ons Epidetiologkal and clinical heterogeneity (1991) (0)
- T-27 Study of new algorithms for non-invasive staging of liver fibrosis in chronic viral hepatitis (CH) and non-alcoholic fatty liver disease (NAFLD) (2013) (0)
- P.1.107: OLGA GASTRITIS STAGING SYSTEM: PRELIMINARY RESULTS FROM A PROSPECTIVE STUDY ON APPROPRIATE USE OF UPPER ENDOSCOPY IN PIEMONTE (OLGAGRUPPI) (2011) (0)
- Portal hypotensive action of type-I calcimimetic compounds in rats with CCl4-induced ascitic liver cirrhosis (2009) (0)
- The colostomized patient:a psycological and psycopathological investigation (1985) (0)
- Renal hyporfusion, glomerular vas efferens vasocostriction and loss of tubular-glomerular freedback in patients with decompensated non-azotemic liver cirrhosis (2001) (0)
- Through the scope (TTS) enteral wallstent for the emergency decompression of acute large bowel obstruction due to colorectal malignancies (2000) (0)
- P.1.230: LAPAROENDOSCOPIC RENDEZVOUS (LER): EVOLUTION OF TECHNIQUE AND COMPLICATIONS IN PATIENTS WITH CHOLECYSTO-CHOLEDOCHOLITHIASIS (CCL) (2011) (0)
- Impact of IL28B genotype on response rates in hepatitis C virus cirrhotic patients treated with new DAA regimens: experience of a single center (2017) (0)
- HLA-B, DRB1 alleles in Italian patients with chronic hepatitis C and responsiveness to interferon + ribavirin therapy (2010) (0)
- 3 OP Hemoclipping for treatment of bleeding angiodysplasia of the cecum (2002) (0)
- PEGINTERFERON ALFA-2A (40KD) (PEGIFN alpha 2A) HAS A WIDE SAFETY MARGIN IN COMBINATION WITH RIBAVIRIN (RBV) 1000/1200 MG/DAY IN PATIENTS INFECTED WITH HCV GENOTYPE 1: POOLED ANALYSIS OF DATA FROM FOUR RANDOMIZED MULTICENTER STUDIES (2009) (0)
- F-8 Importance of HLA-B in the sustained virological response in patients with chronic hepatitis C treated with peg-IFN and ribavirin (2012) (0)
- Helicobacter pylori and ischemic heart disease. Which potential pathogenic mechanisms? (2006) (0)
- Antibodies against GOR in patients undergoing orthotopic liver trasplantation (OLT) (1994) (0)
- 34 Anti-HBc positivity and gender are strongly related to HCC but are not related to treatment outcome (2004) (0)
- One question on the work on antinuclear antibody levels in patients with Hodgkin's and non-Hodgkin's lymphoma. (2008) (0)
- Abstract of scientific presentations19 P Radioferquency energy delivery (stretta procedure) for the treatment of gastro-oesophageal reflux disease: Preliminary data (2002) (0)
- Therapy with direct acting antivirals in patients with hepatitis C virus related lymphoproliferative disorders and mixed cryogloglobulinemia (2017) (0)
- EUS in gastroenterology. New challenges after Turin 2007. (2008) (0)
- Subtypes of specialized intestinal metaplasia (SIM) and risk of adenocarcinoma in long-segment barrett (2000) (0)
- Endosonographic diagnosis of biopsy negative gastric linitis plastica (2001) (0)
- Hepatitis D Virus: An Overview for Dentists (2019) (0)
- UPLC–MS/MS method for quantification of the azathioprine metabolites 6- mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood (0)
- Hepatitis B: therapeutic perspectives. (2001) (0)
- The bacterium behind the 2005 Nobel Prize. (2006) (0)
- IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS (2015) (0)
- 575 Retreatment with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in pegylated interferon α-2b (12KD)/ribavirin non-responders with cirrhosis/advanced fibrosis: Repeat interim analysis (2006) (0)
- P.15.9 FOLLOW UP OF ESOPHAGEAL VARICES AT 3 VS 6 MONTHS AFTER ERADICATION BY ENDOSCOPIC BANDING IN CIRRHOTIC PATIENTS (2012) (0)
- Anti-brush border antibodies (ABBA) in Crohn's disease: Anything new? (2001) (0)
- HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms. (2019) (0)
- P.09.6: Significant Improvement of Glycaemic Control in Diabetic Patients with Chronic Hepatitis C Achieving Sustained Virologic Response after Direct Acting Antiviral Therapy: Results of a Prospective Controlled Study (2017) (0)
- Risk of hepatitis B and efficacy of treatment with lamivudine in patients undergoing allo-SCT (2008) (0)
- The clinical significance of the delta antigen-antibody system in hepatitis B infections. (1982) (0)
- Oxidative stress-inducible factors promote liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease. (2014) (0)
- Role of Helicobacter pylori infection in peptic ulcer haemorrhage. (2006) (0)
- [Immunological study of carriers of Australia antigen (HBsAg)]. (1978) (0)
- P.13.3 MANAGEMENT OF PT1 TUMORS FOUND DURING COLORECTAL SCREENING: OUTCOME AND TREATMENT QUALITY INDICATORS (2014) (0)
- T1990 Peginterferon Alfa-2a (40KD) Has a Wide Safety Margin in Patients Infected With Hepatitis C Virus Genotype 1: Pooled Data From Four Randomized Multicenter Studies (2010) (0)
- Gene expression profiles for predicting treatment response in patients with chronic hepatitis C: preliminary analysis (2007) (0)
- Hepatitis C: new strategies of therapy according to RVR, SVR etc. (2009) (0)
- SLC29A1 −706G>C predict haemoglobin decrease in patients with hepatitis C treated with interferon and ribavirin (2010) (0)
- SOFOSBUVIR PLUS RIBAVIRIN IN HCV-INFECTED CIRRHOTIC PATIENTS AWAITING LIVER TRANSPLANTATION: PRELIMINARY DATA FROM A SINGLE-CENTRE EXPERIENCE (2015) (0)
- From meetings (1988) (0)
- Liver complications in Crohn's disease undergoing surgical intervention (2000) (0)
- Poster SessionsThursday, February 24thT-38 PEG-IFN for hepatitis C in clinical practice: Results of the retrospective phase of the AIFA study (2011) (0)
- Pharyngeal webs in a patient with dysphagia and Behcet’s disease (2011) (0)
- P.1.93: FOLLOW UP OF ESOPHAGEAL VARICES AT 3 VS 6 MONTHS AFTER ERADICATION BY ENDOSCOPIC BANDING IN CIRRHOTIC PATIENTS. A PROSPECTIVE RANDOMIZED TRIAL (2011) (0)
- Hepatitis C virus :clinical significance of anti-HCV and HCV-RNA and characterization of an Italian isolate (1989) (0)
- Endoscopic measurement of variceal pressure in patients with portal hypertension: Correlation with portal pressure (2006) (0)
- The Role of Chimpanzees in Hepatitis D Research (1994) (0)
- Long term lamivudine (LAM) therapy in CHB-E-antigen-negative (CHB-e-Ag-neg): efficacy and breakthroughs (2002) (0)
- LONG-TERM FOLLOW-UP OF CHILDREN WITH BLEEDING ESOPHAGEAL VARICES TREATED BY ENDOSCOPIC BAND LIGATION (2009) (0)
- Need for continuing medical education for liver disease management in Mongolia (2016) (0)
- Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease (2014) (0)
- Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease (2014) (0)
- The prevalence of coeliac disease in patients fulfilling the Rome II criteria for irritable bowel syndrome (2001) (0)
- [Surface antigen (HBsAg) and core antigen (HBcAg) of the Dane particle detected by immunofluorescence in hepatic biopsies in patients with acute and chronic hepatitis]. (1976) (0)
- P995 SORAFENIB VERSUS Y-RADIOEMBOLIZATION FOR ADVANCED MONO-LOBAR HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS: A PRELIMINARY STUDY ON TOLERABILITY AND SURVIVAL (2014) (0)
- Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (OLT). (1995) (0)
- Eradication of Helicobacter pylori infection and methonidazole resistance: different results in different countries. (1998) (0)
- Are autoantibodies (auto-Ab) a serologycal marker for the behaviour of Crohn's disease (CD)? (2000) (0)
- SEDATION FOR ENDOSCOPY IN PATIENTS WITH END-STAGE LIVER DISEASE: RESULTS OF A PROSPECTIVE CONTROLLED STUDY (2009) (0)
- Diagnosis of hepatitis delta virus infection. (1995) (0)
- All oral sofosbuvir-based antiviral therapy in liver transplant recipients affected by moderate-severe hepatitis C recurrence: Predictors of viral response and survival (2016) (0)
- Diagnostic yield of EUS-FNA in the diagnosis of subepithelial lesions of the gastrointestinal tract (2011) (0)
- Emergency catheter probe endoscopic sonography (CP-EUS): an effective procedure in the assessment of a bleeding gangliocytic paraganglioma. (2006) (0)
- Efficacy of clarithromycin plus metronidazole-based triple therapy for Helicobacter pylori eradication: a retrospective study. (2010) (0)
- P0069 : Risk factors for metabolic syndrome after liver transplantation: What has changed over time (2015) (0)
- Endoscopic ultrasound in gastroenterology and beyond. New challenges in the XXI century. (2007) (0)
- Title page (2016) (0)
- P.1.212: YIELD OF ENDOSCOPIC ULTRASOUND (EUS) AND EUS-FNA IN THE DIAGNOSIS AND FOLLOW-UP OF INTRADUCTAL PAPILLARY MUCINOUS TUMORS: A SINGLE CENTRE EXPERIENCE (2011) (0)
- P849 QUANTITATIVE AND QUALITATIVE ANALYSIS OF PLASMA FREE FATTY ACIDS AND THEIR IMPACT ON LIVER DAMAGE IN NAFLD PATIENTS (2014) (0)
- Symposium on management of chronic viral hepatitis focus on intron a interferon alfa 2b monte carlo monaco december 8 9 1989 (1990) (0)
- [Chronic viral hepatitis caused by B and C virus: diagnostic and therapeutic trends]. (1999) (0)
- 47 Outcome of patients transplanted with liver from hepatitis C-positive donors (2000) (0)
- Two Combined Genetic Markers Identify Hepatitis C Recipients With a Lower Graft Survival From The Earliest Post-Transplant Period (2015) (0)
This paper list is powered by the following services:
Other Resources About Mario Rizzetto
What Schools Are Affiliated With Mario Rizzetto?
Mario Rizzetto is affiliated with the following schools:
